
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Rational Design, Synthesis, Characterization and Evaluation of Iodinated 4,4′-Bipyridines as New Transthyretin Fibrillogenesis Inhibitors - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="ABCB7517925F7ED33D75170015926EB2.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="molecules">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7248964/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Molecules">
<meta name="citation_title" content="Rational Design, Synthesis, Characterization and Evaluation of Iodinated 4,4′-Bipyridines as New Transthyretin Fibrillogenesis Inhibitors">
<meta name="citation_author" content="Alessandro Dessì">
<meta name="citation_author_institution" content="Institute of Biomolecular Chemistry ICB, CNR, Secondary Branch of Sassari, Traversa La Crucca 3, Regione Baldinca, Li Punti, 07100 Sassari, Italy; alessandro.dessi@cnr.it (A.D.); roberto.dallocchio@cnr.it (R.D.)">
<meta name="citation_author" content="Paola Peluso">
<meta name="citation_author_institution" content="Institute of Biomolecular Chemistry ICB, CNR, Secondary Branch of Sassari, Traversa La Crucca 3, Regione Baldinca, Li Punti, 07100 Sassari, Italy; alessandro.dessi@cnr.it (A.D.); roberto.dallocchio@cnr.it (R.D.)">
<meta name="citation_author" content="Roberto Dallocchio">
<meta name="citation_author_institution" content="Institute of Biomolecular Chemistry ICB, CNR, Secondary Branch of Sassari, Traversa La Crucca 3, Regione Baldinca, Li Punti, 07100 Sassari, Italy; alessandro.dessi@cnr.it (A.D.); roberto.dallocchio@cnr.it (R.D.)">
<meta name="citation_author" content="Robin Weiss">
<meta name="citation_author_institution" content="Strasbourg Institute of Chemistry, UMR CNRS 7177, Team LASYROC, 1 rue Blaise Pascal, University of Strasbourg, CEDEX, 67008 Strasbourg, France; robin.weiss@unistra.fr (R.W.); ppale@unistra.fr (P.P.)">
<meta name="citation_author" content="Giuseppina Andreotti">
<meta name="citation_author_institution" content="Institute of Biomolecular Chemistry ICB, CNR, Via Campi Flegrei 34, 80078 Pozzuoli (NA), Italy; giuseppina.andreotti@icb.cnr.it (G.A.); mariateresa.allocca@gmail.com (M.A.)">
<meta name="citation_author" content="Mariateresa Allocca">
<meta name="citation_author_institution" content="Institute of Biomolecular Chemistry ICB, CNR, Via Campi Flegrei 34, 80078 Pozzuoli (NA), Italy; giuseppina.andreotti@icb.cnr.it (G.A.); mariateresa.allocca@gmail.com (M.A.)">
<meta name="citation_author_institution" content="Department of Environmental, Biological and Pharmaceutical Sciences and Technologies (DiSTABiF), University of Campania “Luigi Vanvitelli”, Via Vivaldi, 43-81100 Caserta, Italy">
<meta name="citation_author" content="Emmanuel Aubert">
<meta name="citation_author_institution" content="Crystallography, Magnetic Resonance and Modelling (CRM2), UMR CNRS 7036, University of Lorraine, Bd des Aiguillettes, 54506 Vandoeuvre-les-Nancy, France; emmanuel.aubert@univ-lorraine.fr">
<meta name="citation_author" content="Patrick Pale">
<meta name="citation_author_institution" content="Strasbourg Institute of Chemistry, UMR CNRS 7177, Team LASYROC, 1 rue Blaise Pascal, University of Strasbourg, CEDEX, 67008 Strasbourg, France; robin.weiss@unistra.fr (R.W.); ppale@unistra.fr (P.P.)">
<meta name="citation_author" content="Victor Mamane">
<meta name="citation_author_institution" content="Strasbourg Institute of Chemistry, UMR CNRS 7177, Team LASYROC, 1 rue Blaise Pascal, University of Strasbourg, CEDEX, 67008 Strasbourg, France; robin.weiss@unistra.fr (R.W.); ppale@unistra.fr (P.P.)">
<meta name="citation_author" content="Sergio Cossu">
<meta name="citation_author_institution" content="Department of Molecular Science and Nanosystems DSMN, Venice Ca’ Foscari University, Via Torino 155, 30172 Mestre Venezia, Italy; cossu@unive.it">
<meta name="citation_publication_date" content="2020 May 8">
<meta name="citation_volume" content="25">
<meta name="citation_issue" content="9">
<meta name="citation_firstpage" content="2213">
<meta name="citation_doi" content="10.3390/molecules25092213">
<meta name="citation_pmid" content="32397334">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC7248964/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC7248964/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC7248964/pdf/molecules-25-02213.pdf">
<meta name="description" content="The 3,3′,5,5′-tetrachloro-2-iodo-4,4′-bipyridine structure is proposed as a novel chemical scaffold for the design of new transthyretin (TTR) fibrillogenesis inhibitors. In the frame of a proof-of-principle exploration, four chiral ...">
<meta name="og:title" content="Rational Design, Synthesis, Characterization and Evaluation of Iodinated 4,4′-Bipyridines as New Transthyretin Fibrillogenesis Inhibitors">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="The 3,3′,5,5′-tetrachloro-2-iodo-4,4′-bipyridine structure is proposed as a novel chemical scaffold for the design of new transthyretin (TTR) fibrillogenesis inhibitors. In the frame of a proof-of-principle exploration, four chiral ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC7248964/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://pmc.ncbi.nlm.nih.gov/search/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="7248964">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.3390/molecules25092213"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/molecules-25-02213.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC7248964%2F%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/7248964/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/7248964/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC7248964/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-molecules.png" alt="Molecules logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Molecules" title="Link to Molecules" shape="default" href="http://www.mdpi.com/journal/molecules" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Molecules</button></div>. 2020 May 8;25(9):2213. doi: <a href="https://doi.org/10.3390/molecules25092213" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.3390/molecules25092213</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://pmc.ncbi.nlm.nih.gov/search/?term=%22Molecules%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Molecules%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Molecules%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Molecules%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Rational Design, Synthesis, Characterization and Evaluation of Iodinated 4,4′-Bipyridines as New Transthyretin Fibrillogenesis Inhibitors</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Dess%C3%AC%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Alessandro Dessì</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Alessandro Dessì</span></h3>
<div class="p">
<sup>1</sup>Institute of Biomolecular Chemistry ICB, CNR, Secondary Branch of Sassari, Traversa La Crucca 3, Regione Baldinca, Li Punti, 07100 Sassari, Italy; alessandro.dessi@cnr.it (A.D.); roberto.dallocchio@cnr.it (R.D.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Dess%C3%AC%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Alessandro Dessì</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Peluso%20P%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Paola Peluso</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Paola Peluso</span></h3>
<div class="p">
<sup>1</sup>Institute of Biomolecular Chemistry ICB, CNR, Secondary Branch of Sassari, Traversa La Crucca 3, Regione Baldinca, Li Punti, 07100 Sassari, Italy; alessandro.dessi@cnr.it (A.D.); roberto.dallocchio@cnr.it (R.D.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Peluso%20P%22%5BAuthor%5D" class="usa-link"><span class="name western">Paola Peluso</span></a>
</div>
</div>
<sup>1,</sup><sup>*</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Dallocchio%20R%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Roberto Dallocchio</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Roberto Dallocchio</span></h3>
<div class="p">
<sup>1</sup>Institute of Biomolecular Chemistry ICB, CNR, Secondary Branch of Sassari, Traversa La Crucca 3, Regione Baldinca, Li Punti, 07100 Sassari, Italy; alessandro.dessi@cnr.it (A.D.); roberto.dallocchio@cnr.it (R.D.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Dallocchio%20R%22%5BAuthor%5D" class="usa-link"><span class="name western">Roberto Dallocchio</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Weiss%20R%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Robin Weiss</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Robin Weiss</span></h3>
<div class="p">
<sup>2</sup>Strasbourg Institute of Chemistry, UMR CNRS 7177, Team LASYROC, 1 rue Blaise Pascal, University of Strasbourg, CEDEX, 67008 Strasbourg, France; robin.weiss@unistra.fr (R.W.); ppale@unistra.fr (P.P.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Weiss%20R%22%5BAuthor%5D" class="usa-link"><span class="name western">Robin Weiss</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Andreotti%20G%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Giuseppina Andreotti</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Giuseppina Andreotti</span></h3>
<div class="p">
<sup>3</sup>Institute of Biomolecular Chemistry ICB, CNR, Via Campi Flegrei 34, 80078 Pozzuoli (NA), Italy; giuseppina.andreotti@icb.cnr.it (G.A.); mariateresa.allocca@gmail.com (M.A.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Andreotti%20G%22%5BAuthor%5D" class="usa-link"><span class="name western">Giuseppina Andreotti</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Allocca%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Mariateresa Allocca</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Mariateresa Allocca</span></h3>
<div class="p">
<sup>3</sup>Institute of Biomolecular Chemistry ICB, CNR, Via Campi Flegrei 34, 80078 Pozzuoli (NA), Italy; giuseppina.andreotti@icb.cnr.it (G.A.); mariateresa.allocca@gmail.com (M.A.)</div>
<div class="p">
<sup>4</sup>Department of Environmental, Biological and Pharmaceutical Sciences and Technologies (DiSTABiF), University of Campania “Luigi Vanvitelli”, Via Vivaldi, 43-81100 Caserta, Italy</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Allocca%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Mariateresa Allocca</span></a>
</div>
</div>
<sup>3,</sup><sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Aubert%20E%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Emmanuel Aubert</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Emmanuel Aubert</span></h3>
<div class="p">
<sup>5</sup>Crystallography, Magnetic Resonance and Modelling (CRM2), UMR CNRS 7036, University of Lorraine, Bd des Aiguillettes, 54506 Vandoeuvre-les-Nancy, France; emmanuel.aubert@univ-lorraine.fr</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Aubert%20E%22%5BAuthor%5D" class="usa-link"><span class="name western">Emmanuel Aubert</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Pale%20P%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Patrick Pale</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Patrick Pale</span></h3>
<div class="p">
<sup>2</sup>Strasbourg Institute of Chemistry, UMR CNRS 7177, Team LASYROC, 1 rue Blaise Pascal, University of Strasbourg, CEDEX, 67008 Strasbourg, France; robin.weiss@unistra.fr (R.W.); ppale@unistra.fr (P.P.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Pale%20P%22%5BAuthor%5D" class="usa-link"><span class="name western">Patrick Pale</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mamane%20V%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Victor Mamane</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Victor Mamane</span></h3>
<div class="p">
<sup>2</sup>Strasbourg Institute of Chemistry, UMR CNRS 7177, Team LASYROC, 1 rue Blaise Pascal, University of Strasbourg, CEDEX, 67008 Strasbourg, France; robin.weiss@unistra.fr (R.W.); ppale@unistra.fr (P.P.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mamane%20V%22%5BAuthor%5D" class="usa-link"><span class="name western">Victor Mamane</span></a>
</div>
</div>
<sup>2,</sup><sup>*</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cossu%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Sergio Cossu</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Sergio Cossu</span></h3>
<div class="p">
<sup>6</sup>Department of Molecular Science and Nanosystems DSMN, Venice Ca’ Foscari University, Via Torino 155, 30172 Mestre Venezia, Italy; cossu@unive.it</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cossu%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Sergio Cossu</span></a>
</div>
</div>
<sup>6</sup>
</div>
<div class="cg p">Editor: <span class="name western">Maged Henary</span>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="af1-molecules-25-02213">
<sup>1</sup>Institute of Biomolecular Chemistry ICB, CNR, Secondary Branch of Sassari, Traversa La Crucca 3, Regione Baldinca, Li Punti, 07100 Sassari, Italy; alessandro.dessi@cnr.it (A.D.); roberto.dallocchio@cnr.it (R.D.)</div>
<div id="af2-molecules-25-02213">
<sup>2</sup>Strasbourg Institute of Chemistry, UMR CNRS 7177, Team LASYROC, 1 rue Blaise Pascal, University of Strasbourg, CEDEX, 67008 Strasbourg, France; robin.weiss@unistra.fr (R.W.); ppale@unistra.fr (P.P.)</div>
<div id="af3-molecules-25-02213">
<sup>3</sup>Institute of Biomolecular Chemistry ICB, CNR, Via Campi Flegrei 34, 80078 Pozzuoli (NA), Italy; giuseppina.andreotti@icb.cnr.it (G.A.); mariateresa.allocca@gmail.com (M.A.)</div>
<div id="af4-molecules-25-02213">
<sup>4</sup>Department of Environmental, Biological and Pharmaceutical Sciences and Technologies (DiSTABiF), University of Campania “Luigi Vanvitelli”, Via Vivaldi, 43-81100 Caserta, Italy</div>
<div id="af5-molecules-25-02213">
<sup>5</sup>Crystallography, Magnetic Resonance and Modelling (CRM2), UMR CNRS 7036, University of Lorraine, Bd des Aiguillettes, 54506 Vandoeuvre-les-Nancy, France; emmanuel.aubert@univ-lorraine.fr</div>
<div id="af6-molecules-25-02213">
<sup>6</sup>Department of Molecular Science and Nanosystems DSMN, Venice Ca’ Foscari University, Via Torino 155, 30172 Mestre Venezia, Italy; cossu@unive.it</div>
<div class="author-notes p"><div class="fn" id="c1-molecules-25-02213">
<sup>*</sup><p class="display-inline">Correspondence: <span>paola.peluso@cnr.it</span> (P.P.); <span>vmamane@unistra.fr</span> (V.M.); Tel.: +39-079-2841218 (P.P.); +33-3-68851612 (V.M.)</p>
</div></div>
<h4 class="font-secondary">Roles</h4>
<div class="p">
<strong class="contrib"><span class="name western">Maged Henary</span></strong>: <span class="role">Academic Editor</span>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2020 Apr 16; Accepted 2020 May 6; Collection date 2020 May.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2020 by the authors.</div>
<p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<a href="http://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by/4.0/</a>).</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC7248964  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32397334/" class="usa-link">32397334</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<p>The 3,3′,5,5′-tetrachloro-2-iodo-4,4′-bipyridine structure is proposed as a novel chemical scaffold for the design of new transthyretin (TTR) fibrillogenesis inhibitors. In the frame of a proof-of-principle exploration, four chiral 3,3′,5,5′-tetrachloro-2-iodo-2′-substituted-4,4′- bipyridines were rationally designed and prepared from a simple trihalopyridine in three steps, including a Cu-catalysed Finkelstein reaction to introduce iodine atoms on the heteroaromatic scaffold, and a Pd-catalysed coupling reaction to install the 2′-substituent. The corresponding racemates, along with other five chiral 4,4′-bipyridines containing halogens as substituents, were enantioseparated by high-performance liquid chromatography in order to obtain pure enantiomer pairs. All stereoisomers were tested against the amyloid fibril formation (FF) of wild type (WT)-TTR and two mutant variants, V30M and Y78F, in acid mediated aggregation experiments. Among the 4,4′-bipyridine derivatives, interesting inhibition activity was obtained for both enantiomers of the 3,3′,5,5′-tetrachloro-2′-(4-hydroxyphenyl)-2-iodo-4,4′-bipyridine. In silico docking studies were carried out in order to explore possible binding modes of the 4,4′-bipyridine derivatives into the TTR. The gained results point out the importance of the right combination of H-bond sites and the presence of iodine as halogen-bond donor. Both experimental and theoretical evidences pave the way for the utilization of the iodinated 4,4′-bipyridine core as template to design new promising inhibitors of TTR amyloidogenesis.</p>
<section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> bipyridines, docking, fibril formation, halogen bond, misfolding inhibition, transthyretin</p></section></section><section id="sec1-molecules-25-02213"><h2 class="pmc_sec_title">1. Introduction</h2>
<p>Human transthyretin (hTTR, prealbumin) is a homotetrameric protein (55 kDa) made up of four subunits (A-B-C-D, <a href="#molecules-25-02213-f001" class="usa-link">Figure 1</a>a), each composed of 127 aminoacids [<a href="#B1-molecules-25-02213" class="usa-link" aria-describedby="B1-molecules-25-02213">1</a>,<a href="#B2-molecules-25-02213" class="usa-link" aria-describedby="B2-molecules-25-02213">2</a>,<a href="#B3-molecules-25-02213" class="usa-link" aria-describedby="B3-molecules-25-02213">3</a>]. The protein is mainly produced by the liver, but other sources of TTR, including the choroid plexus, the retinal pigment epithelium, and the α-cells of pancreatic islets are known. TTR is involved in the transport of thyroid hormones (thyroxine (T<sub>4</sub>) and triiodothyronine (T<sub>3</sub>)) (<a href="#molecules-25-02213-f001" class="usa-link">Figure 1</a>b) in blood and cerebrospinal fluid. The tetrameric assembly of TTR contains a central hydrophobic channel with two symmetrical funnel-shaped T<sub>4</sub> binding pockets located at the energetically weaker dimer-dimer A-B/C-D interface [<a href="#B4-molecules-25-02213" class="usa-link" aria-describedby="B4-molecules-25-02213">4</a>], the other A-C/B-D interface being stabilized by interstrand hydrogen bonds (HBs).</p>
<figure class="fig xbox font-sm" id="molecules-25-02213-f001"><h3 class="obj_head">Figure 1.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=7248964_molecules-25-02213-g001.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4224/7248964/924be84eb79f/molecules-25-02213-g001.jpg" loading="lazy" height="393" width="762" alt="Figure 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/molecules-25-02213-f001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(<strong>a</strong>) Ribbon diagram picture of wild type (WT)-TTR (released from PDB ID 1ICT [<a href="#B2-molecules-25-02213" class="usa-link" aria-describedby="B2-molecules-25-02213">2</a>]); (<strong>b</strong>) structures of thyroxine (T<sub>4</sub>), triiodothyronine (T<sub>3</sub>), tafamidis and other ATTR drug candidates under clinical trials.</p></figcaption></figure><p>The presence of mutations in TTR results in destabilization of the tetramer and dissociation into amyloidogenic monomers, which misfold and self-aggregate into insoluble amyloid fibrils. TTR amyloidogenesis has been implicated to cause amyloid diseases (TTR amyloidosis, ATTR) [<a href="#B5-molecules-25-02213" class="usa-link" aria-describedby="B5-molecules-25-02213">5</a>,<a href="#B6-molecules-25-02213" class="usa-link" aria-describedby="B6-molecules-25-02213">6</a>]. Amyloid structures derived from wild-type (WT)-TTR can deposit in the heart and peripheral nerves causing senile systemic amyloidosis (SSA), whereas over 100 TTR mutants were shown to be implicated in three other groups of diseases, namely familial amyloidotic polyneuropathy (FAP), cardiomyopathy (FAC), and central nervous system selective amyloidosis (CNSA). Among known TTR mutants, the V30M [<a href="#B7-molecules-25-02213" class="usa-link" aria-describedby="B7-molecules-25-02213">7</a>] and the Y78F [<a href="#B8-molecules-25-02213" class="usa-link" aria-describedby="B8-molecules-25-02213">8</a>] are the most common FAP mutation and the most amyloidogenic, respectively. Moreover, the importance of TTR stability also concerns neurodegenerative disorders such as Parkinson’s and Alzheimer’s diseases [<a href="#B9-molecules-25-02213" class="usa-link" aria-describedby="B9-molecules-25-02213">9</a>,<a href="#B10-molecules-25-02213" class="usa-link" aria-describedby="B10-molecules-25-02213">10</a>]. </p>
<p>In 1996 it was observed that T<sub>4</sub> is able to prevent amyloid fibril formation (FF), but with adverse side effects due to its hormonal activity [<a href="#B11-molecules-25-02213" class="usa-link" aria-describedby="B11-molecules-25-02213">11</a>]. However, this study proved that stabilization of the native TTR tetramer by small molecule binding to one or both of the T<sub>4</sub> binding pockets could be a rationale for the kinetic inhibition of TTR amyloidogenesis, tetramer dissociation being the rate-determining step in amyloid formation [<a href="#B12-molecules-25-02213" class="usa-link" aria-describedby="B12-molecules-25-02213">12</a>,<a href="#B13-molecules-25-02213" class="usa-link" aria-describedby="B13-molecules-25-02213">13</a>]. Indeed, TTR can bind molecules other than T<sub>4</sub> because more than 99% of T<sub>4</sub> binding sites are unoccupied due to the fact that two other carriers, albumin and thyroid-binding globulin, transport the majority of T<sub>4</sub> in the blood. Significantly, this observation paved the way for the development of an oral therapy as a valid alternative to more invasive approaches [<a href="#B14-molecules-25-02213" class="usa-link" aria-describedby="B14-molecules-25-02213">14</a>].</p>
<p>In the last decades, several small molecules have proven to be able to bridge neighbouring monomers of TTR via specific hydrophobic and electrostatic noncovalent interactions, to stabilize the tetramer, to inhibit the tetramer dissociation, and to reduce FF [<a href="#B3-molecules-25-02213" class="usa-link" aria-describedby="B3-molecules-25-02213">3</a>,<a href="#B15-molecules-25-02213" class="usa-link" aria-describedby="B15-molecules-25-02213">15</a>,<a href="#B16-molecules-25-02213" class="usa-link" aria-describedby="B16-molecules-25-02213">16</a>,<a href="#B17-molecules-25-02213" class="usa-link" aria-describedby="B17-molecules-25-02213">17</a>,<a href="#B18-molecules-25-02213" class="usa-link" aria-describedby="B18-molecules-25-02213">18</a>,<a href="#B19-molecules-25-02213" class="usa-link" aria-describedby="B19-molecules-25-02213">19</a>,<a href="#B20-molecules-25-02213" class="usa-link" aria-describedby="B20-molecules-25-02213">20</a>,<a href="#B21-molecules-25-02213" class="usa-link" aria-describedby="B21-molecules-25-02213">21</a>,<a href="#B22-molecules-25-02213" class="usa-link" aria-describedby="B22-molecules-25-02213">22</a>,<a href="#B23-molecules-25-02213" class="usa-link" aria-describedby="B23-molecules-25-02213">23</a>,<a href="#B24-molecules-25-02213" class="usa-link" aria-describedby="B24-molecules-25-02213">24</a>,<a href="#B25-molecules-25-02213" class="usa-link" aria-describedby="B25-molecules-25-02213">25</a>,<a href="#B26-molecules-25-02213" class="usa-link" aria-describedby="B26-molecules-25-02213">26</a>,<a href="#B27-molecules-25-02213" class="usa-link" aria-describedby="B27-molecules-25-02213">27</a>,<a href="#B28-molecules-25-02213" class="usa-link" aria-describedby="B28-molecules-25-02213">28</a>]. However, to date few structures possess the requirements to be drug candidates (<a href="#molecules-25-02213-f001" class="usa-link">Figure 1</a>b), and the ATTR still lacks an effective therapy. So far, tafamidis [<a href="#B29-molecules-25-02213" class="usa-link" aria-describedby="B29-molecules-25-02213">29</a>] has been approved for clinical use in Europe and Japan for the treatment of early-stage FAP [<a href="#B30-molecules-25-02213" class="usa-link" aria-describedby="B30-molecules-25-02213">30</a>], but advanced disease responds poorly to tafamidis administration [<a href="#B31-molecules-25-02213" class="usa-link" aria-describedby="B31-molecules-25-02213">31</a>]. Then, recently the drug tolcapone, which was approved for the treatment of Parkinson’s disease, has been repurposed for the treatment of ATTR [<a href="#B32-molecules-25-02213" class="usa-link" aria-describedby="B32-molecules-25-02213">32</a>]. Nonsteroidal anti-inflammatory drugs (NSAIDs) also inhibit formation of amyloidogenic monomers. Among them, diflunisal was shown to slow the progression of FAP over a period of 2 years, but adverse gastrointestinal effects limit its use [<a href="#B16-molecules-25-02213" class="usa-link" aria-describedby="B16-molecules-25-02213">16</a>,<a href="#B33-molecules-25-02213" class="usa-link" aria-describedby="B33-molecules-25-02213">33</a>]. In this regard, it is worth mentioning that small molecules should be selective for TTR and neither bind thyroid hormone receptors nor cyclooxygenase-1 (COX-1) to be effective clinical candidates [<a href="#B16-molecules-25-02213" class="usa-link" aria-describedby="B16-molecules-25-02213">16</a>,<a href="#B18-molecules-25-02213" class="usa-link" aria-describedby="B18-molecules-25-02213">18</a>].</p>
<p>Over time, a large number of SAR studies have been published in order to identify typical substructures which are shared by compounds that stabilize TTR tetramer [<a href="#B3-molecules-25-02213" class="usa-link" aria-describedby="B3-molecules-25-02213">3</a>,<a href="#B34-molecules-25-02213" class="usa-link" aria-describedby="B34-molecules-25-02213">34</a>,<a href="#B35-molecules-25-02213" class="usa-link" aria-describedby="B35-molecules-25-02213">35</a>,<a href="#B36-molecules-25-02213" class="usa-link" aria-describedby="B36-molecules-25-02213">36</a>,<a href="#B37-molecules-25-02213" class="usa-link" aria-describedby="B37-molecules-25-02213">37</a>,<a href="#B38-molecules-25-02213" class="usa-link" aria-describedby="B38-molecules-25-02213">38</a>,<a href="#B39-molecules-25-02213" class="usa-link" aria-describedby="B39-molecules-25-02213">39</a>]. In this field, the potential of iodine as substituent (iodination hypothesis) has been intensively explored through evaluating the inhibition ability of iodinated compounds with respect to non-iodinated analogues [<a href="#B10-molecules-25-02213" class="usa-link" aria-describedby="B10-molecules-25-02213">10</a>,<a href="#B11-molecules-25-02213" class="usa-link" aria-describedby="B11-molecules-25-02213">11</a>,<a href="#B17-molecules-25-02213" class="usa-link" aria-describedby="B17-molecules-25-02213">17</a>,<a href="#B36-molecules-25-02213" class="usa-link" aria-describedby="B36-molecules-25-02213">36</a>,<a href="#B40-molecules-25-02213" class="usa-link" aria-describedby="B40-molecules-25-02213">40</a>,<a href="#B41-molecules-25-02213" class="usa-link" aria-describedby="B41-molecules-25-02213">41</a>,<a href="#B42-molecules-25-02213" class="usa-link" aria-describedby="B42-molecules-25-02213">42</a>,<a href="#B43-molecules-25-02213" class="usa-link" aria-describedby="B43-molecules-25-02213">43</a>]. Among iodinated motifs, 2,4,6-triiodophenol proved to be one of the most potent TTR fibrillogenesis inhibitor known so far [<a href="#B11-molecules-25-02213" class="usa-link" aria-describedby="B11-molecules-25-02213">11</a>], and iododiflunisal was shown to stabilize TTR [<a href="#B17-molecules-25-02213" class="usa-link" aria-describedby="B17-molecules-25-02213">17</a>]. Nevertheless, in some cases iodination does not improve inhibition activity [<a href="#B17-molecules-25-02213" class="usa-link" aria-describedby="B17-molecules-25-02213">17</a>,<a href="#B42-molecules-25-02213" class="usa-link" aria-describedby="B42-molecules-25-02213">42</a>,<a href="#B44-molecules-25-02213" class="usa-link" aria-describedby="B44-molecules-25-02213">44</a>], the effectiveness of this strategy depending on inhibitor scaffold structure and location of iodine in the molecular framework [<a href="#B42-molecules-25-02213" class="usa-link" aria-describedby="B42-molecules-25-02213">42</a>]. In general, the real function of iodine in TTR binding and stabilization still remains unclear due to the fact that halogens as substituents can contribute to protein-ligand binding through multiple roles such as hydrophobic centres, HB acceptors and electrophilic halogen bond (XB) donors. In particular, XBs were found to have a relevant role in the binding of halogenated ligands with proteins [<a href="#B42-molecules-25-02213" class="usa-link" aria-describedby="B42-molecules-25-02213">42</a>,<a href="#B45-molecules-25-02213" class="usa-link" aria-describedby="B45-molecules-25-02213">45</a>], and short I···O contacts were found to underlie the selective binding of T<sub>4</sub> to TTR [<a href="#B46-molecules-25-02213" class="usa-link" aria-describedby="B46-molecules-25-02213">46</a>]. Despite the potential of iodine substituents to contribute to TTR stabilization, studies on iodinated compounds are reported in smaller degree compared to compounds containing fluorine, chlorine and bromine as substituents. Currently, the scarce availability of iodinated compounds has clearly limited the study of the iodine effect on TTR misfolding inhibition, reducing the possibility to gather conclusive information on iodine function. </p>
<p>In the last few years, our groups have reported the synthesis and characterization of halogenated 4,4′-bipyridines [<a href="#B47-molecules-25-02213" class="usa-link" aria-describedby="B47-molecules-25-02213">47</a>,<a href="#B48-molecules-25-02213" class="usa-link" aria-describedby="B48-molecules-25-02213">48</a>,<a href="#B49-molecules-25-02213" class="usa-link" aria-describedby="B49-molecules-25-02213">49</a>,<a href="#B50-molecules-25-02213" class="usa-link" aria-describedby="B50-molecules-25-02213">50</a>]. These molecules were shown to be efficient as XB donors in the solid state [<a href="#B48-molecules-25-02213" class="usa-link" aria-describedby="B48-molecules-25-02213">48</a>] and in solution [<a href="#B51-molecules-25-02213" class="usa-link" aria-describedby="B51-molecules-25-02213">51</a>,<a href="#B52-molecules-25-02213" class="usa-link" aria-describedby="B52-molecules-25-02213">52</a>]. On this basis, starting from the chemistry and properties of 4,4′-bipyridines <strong>1</strong>–<strong>5</strong> [<a href="#B48-molecules-25-02213" class="usa-link" aria-describedby="B48-molecules-25-02213">48</a>], we describe herein the design and synthesis of iodinated 4,4′-bipyridines <strong>6</strong>–<strong>10</strong> and their evaluation as TTR fibrillogenesis inhibitor (<a href="#molecules-25-02213-f002" class="usa-link">Figure 2</a>a). Due to the atropisomeric geometry of their halogenated heteroaromatic scaffold, compounds <strong>1</strong>–<strong>5</strong> and <strong>7</strong>–<strong>10</strong> are chiral and exhibit (<em>M</em>)- and (<em>P</em>)-enantiomers (<a href="#molecules-25-02213-f002" class="usa-link">Figure 2</a>b). Quantitative evaluation of the inhibition efficacy of both (<em>M</em>)- and (<em>P</em>)-enantiomers against TTR misfolding was performed through acid-mediated in vitro assays of WT-, V30M-, and Y78F-TTR aggregation. The relationship between chemical structures, inhibition activity, and binding mode was explored by molecular docking and electrostatic potential isosurfaces (<em>V</em><sub>S</sub>) analysis.</p>
<figure class="fig xbox font-sm" id="molecules-25-02213-f002"><h3 class="obj_head">Figure 2.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=7248964_molecules-25-02213-g002.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4224/7248964/b28cd5b22092/molecules-25-02213-g002.jpg" loading="lazy" height="581" width="781" alt="Figure 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/molecules-25-02213-f002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(<strong>a</strong>) Structures of halogenated 4,4′-bipyridines <strong>1</strong>–<strong>10</strong>; (<strong>b</strong>) (<em>M</em>) and (<em>P</em>) absolute configurations of the atropisomeric 4,4′-bipyridines <strong>1</strong>–<strong>5</strong> and <strong>7</strong>–<strong>10</strong>.</p></figcaption></figure><p>In particular, this study aims at gathering information on the potential role of substructures containing halogen σ-holes in TTR binding and stabilization. It is noteworthy that halogenated 4,4′-bipyridines derivatives have never been designed nor tested as TTR fibrillogenesis inhibitors.</p></section><section id="sec2-molecules-25-02213"><h2 class="pmc_sec_title">2. Results and Discussion</h2>
<section id="sec2dot1-molecules-25-02213"><h3 class="pmc_sec_title">2.1. Rational Design</h3>
<p>In the majority of the TTR:small molecule crystal structures reported to date [<a href="#B3-molecules-25-02213" class="usa-link" aria-describedby="B3-molecules-25-02213">3</a>], the molecule is bound to the T<sub>4</sub> binding site, with the exception of polyphenol (−)-epigallocatechin gallate (EGCG) which binds TTR molecular surface [<a href="#B19-molecules-25-02213" class="usa-link" aria-describedby="B19-molecules-25-02213">19</a>] and few other allosteric inhibitors [<a href="#B24-molecules-25-02213" class="usa-link" aria-describedby="B24-molecules-25-02213">24</a>,<a href="#B25-molecules-25-02213" class="usa-link" aria-describedby="B25-molecules-25-02213">25</a>]. Each T<sub>4</sub> binding pocket is composed of a small inner cavity (delimited by the pair Ser<sub>117</sub>/Se<sub>117’</sub>), and a large outer cavity (delimited by the pair Lys<sub>15</sub>/Lys<sub>15’</sub>), with three pairs of symmetric hydrophobic depressions named halogen binding pockets (hBPs) (<a href="#molecules-25-02213-f003" class="usa-link">Figure 3</a>) where the iodine atoms of T<sub>4</sub> are located.</p>
<figure class="fig xbox font-sm" id="molecules-25-02213-f003"><h4 class="obj_head">Figure 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=7248964_molecules-25-02213-g003.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4224/7248964/4eb34cc90ed5/molecules-25-02213-g003.jpg" loading="lazy" height="549" width="701" alt="Figure 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/molecules-25-02213-f003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Expanded schematic view of one of the two T<sub>4</sub> binding pockets (dimer BD), where hBP<sub>1</sub> is located between the side chains of Lys<sub>15</sub>/<sub>15’</sub>, Leu<sub>17</sub>/<sub>17’</sub>, Thr<sub>106</sub>/<sub>106’</sub> and Val<sub>121</sub>/<sub>121’</sub>, hBP<sub>2</sub> between the side chains of Leu<sub>17</sub>/<sub>17’</sub>, Ala<sub>108</sub>/<sub>108’</sub>, Ala<sub>109</sub>/<sub>109’</sub> and Leu<sub>110</sub>/<sub>110’</sub> and hBP<sub>3</sub> between the side chains of Ser<sub>117</sub>/<sub>117’</sub>, Thr<sub>119</sub>/<sub>119’</sub>, Ala<sub>108</sub>/<sub>108’</sub> and Leu<sub>110</sub>/<sub>110’</sub>.</p></figcaption></figure><p>As reported by Kelly and co-workers [<a href="#B53-molecules-25-02213" class="usa-link" aria-describedby="B53-molecules-25-02213">53</a>], typical inhibitors are characterized by two aryl rings (Ar<em><sub>O</sub></em> and Ar<em><sub>I</sub></em>) connected directly or through a linker. The binding ability of this kind of molecules can be modulated by tuning structure and substitution pattern of the three substructures, namely Ar<em><sub>O</sub></em>, Ar<em><sub>I</sub></em> and linker. Scaffolds bearing halogen substituents on one ring, and a HB centre on the other ring, which is able to interact with Lys<sub>15</sub> ε-NH<sub>3</sub><sup>+</sup> group, represent the typical motif of most inhibitors reported so far. In general, TTR can accommodate small molecules with different orientations. Indeed, in the forward binding mode, the phenyl ring substituted with halogens prefers the inner cavity, whereas in the reverse binding mode it is located in the outer cavity [<a href="#B3-molecules-25-02213" class="usa-link" aria-describedby="B3-molecules-25-02213">3</a>,<a href="#B15-molecules-25-02213" class="usa-link" aria-describedby="B15-molecules-25-02213">15</a>,<a href="#B16-molecules-25-02213" class="usa-link" aria-describedby="B16-molecules-25-02213">16</a>].</p>
<section id="sec2dot1dot1-molecules-25-02213"><h4 class="pmc_sec_title">2.1.1. Conceptual Basis</h4>
<p>As reported [<a href="#B3-molecules-25-02213" class="usa-link" aria-describedby="B3-molecules-25-02213">3</a>,<a href="#B42-molecules-25-02213" class="usa-link" aria-describedby="B42-molecules-25-02213">42</a>,<a href="#B46-molecules-25-02213" class="usa-link" aria-describedby="B46-molecules-25-02213">46</a>], the possibility of XB formation emerges from the crystallographic analysis of complexes between TTR and some of the halogenated ligands reported so far. Indeed, contacts ranging from 2.8 to 3.5 Å have been observed between halogen substituents of small molecules and Ala<sub>109</sub>, Ser<sub>117</sub>, and Thr<sub>119</sub> carbonyls in TTR, acting as XB acceptors. The XB is a noncovalent interaction which originates from the anisotropic charge distribution of bound halogens, generating an area of lower electron density, the electrophilic σ-hole, located on the elongation of the covalent bond (<a href="#molecules-25-02213-f004" class="usa-link">Figure 4</a>a) [<a href="#B54-molecules-25-02213" class="usa-link" aria-describedby="B54-molecules-25-02213">54</a>].</p>
<figure class="fig xbox font-sm" id="molecules-25-02213-f004"><h5 class="obj_head">Figure 4.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=7248964_molecules-25-02213-g004.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4224/7248964/c4b0f2e08209/molecules-25-02213-g004.jpg" loading="lazy" height="343" width="738" alt="Figure 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/molecules-25-02213-f004/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(<strong>a</strong>) Schematic description of XB. On X surface, electrostatic potential (<em>V</em><sub>S</sub>) &gt; 0 (lower electron density) and <em>V</em><sub>S</sub> &lt; 0 (higher electron density) are indicated in blue and red, respectively. Intermediate values are in orange, yellow, and green; (<strong>b</strong>) and (<strong>c</strong>) positions of nitrogen <em>V</em><sub>S,min</sub> regions (blue) and <em>V</em><sub>S,max</sub> in the structure of halogenated 4,4′-bipyridines <strong>1</strong>–<strong>5</strong> and <strong>6</strong> (hydrogen, white). <em>V</em><sub>S,max</sub> colors: halogen, coral; chlorine, green; iodine, purple.</p></figcaption></figure><p>From this perspective, the electrostatic potential (<em>V</em>) is a useful tool for understanding molecular interactive capability. In particular, the calculated positive <em>V</em> on the isodensity surface near the halogen σ-hole, the <em>V</em><sub>S,max</sub>, is advantageously used to assess σ-hole depth which, in turn, has been found to be related to the strengths of XB [<a href="#B55-molecules-25-02213" class="usa-link" aria-describedby="B55-molecules-25-02213">55</a>,<a href="#B56-molecules-25-02213" class="usa-link" aria-describedby="B56-molecules-25-02213">56</a>]. On this basis, the <em>V</em><sub>S</sub> values on a 0.002 au molecular isosurface of polyhalogenated 4,4′-bipyridines <strong>1</strong>–<strong>6</strong>, bearing iodines and chlorines as substituents, were calculated in order to localize regions of higher (negative <em>V</em><sub>S,min</sub>) and lower (positive <em>V</em><sub>S,max</sub>) electron charge density, and to profile the binding capability of diverse halogenated 4,4′-bipyridyl scaffolds as templates for the design of new TTR stabilizers (<a href="#molecules-25-02213-f004" class="usa-link">Figure 4</a>b,c). Several key structural aspects in halogenated 4,4′-bipyridines highlight the interest of studying this family of molecules:</p>
<ul class="list" style="list-style-type:none">
<li>
<span class="label">(i)</span><p class="display-inline">4,4′-Bipyridines <strong>1</strong>–<strong>6</strong> consist of two linked heteroaromatic rings that accommodate six (<strong>1</strong>–<strong>5</strong>) and five (<strong>6</strong>) (<a href="#molecules-25-02213-f004" class="usa-link">Figure 4</a>b,c) highly oriented halogens as substituents. 4,4′-Bipyridyl derivatives have been almost unexplored in the field of TTR stabilization to date, and only the 5-cyano-2-methyl-3,4’-bipyridin-6(1<em>H</em>)-one milrinone was found to be a strong competitive inhibitor of T<sub>4</sub> binding to TTR [<a href="#B57-molecules-25-02213" class="usa-link" aria-describedby="B57-molecules-25-02213">57</a>];</p>
</li>
<li>
<span class="label">(ii)</span><p class="display-inline">The two electron-poor bipyridyl rings are characterized by positive <em>V</em><sub>S,max</sub> ranging from 72.06 to 96.58 kJ/mol (<a href="#app1-molecules-25-02213" class="usa-link">Supplementary Materials, Table S1</a>), similar to the values calculated for tafamidis, which contains an electron-poor substructure centred on the oxazole ring (98.49; 98.88 kJ/mol) (<a href="#app1-molecules-25-02213" class="usa-link">Table S2</a>);</p>
</li>
<li>
<span class="label">(iii)</span><p class="display-inline">The presence of four 3,3′,5,5′-substituents induces chirality by restricted rotation around the 4,4′-bond (atropisomerism), introducing stereochemical features that could be fruitfully exploited to improve binding efficacy and selectivity toward TTR. So far, few studies considered chiral inhibitors and their stereochemical properties [<a href="#B35-molecules-25-02213" class="usa-link" aria-describedby="B35-molecules-25-02213">35</a>]. Moreover, the atropisomeric structure of the 3,3′,5,5′-tetrasubstituted-4,4′-bipyridyl ring mimics the skewed conformation of T<sub>4</sub>;</p>
</li>
<li>
<span class="label">(iv)</span><p class="display-inline">The two pyridyl nitrogens can work as HB acceptors, exhibiting <em>V</em><sub>S,min</sub> values ranging from −122.43 to −117.07 kJ/mol (<a href="#app1-molecules-25-02213" class="usa-link">Supplementary Materials, Table S1</a>). Furthermore, nitrogen is known to be a high-impact design element because substitution of a CH group with a N atom, in aromatic and heteroaromatic ring frameworks, often improves the pharmacological profile of a molecular structure at different levels [<a href="#B58-molecules-25-02213" class="usa-link" aria-describedby="B58-molecules-25-02213">58</a>];</p>
</li>
<li>
<span class="label">(v)</span><p class="display-inline">Iodine is considered a powerful XB donor due to its polarizability, in particular when it is bound to electron-withdrawing groups (EWGs). T<sub>4</sub> presents multiple iodine atoms which are accommodated in the hBPs of the T<sub>4</sub> binding site of TTR. For T<sub>4</sub>, we calculated <em>V</em><sub>S,max</sub> ranging from 109.11 to 143.05 kJ/mol (<a href="#app1-molecules-25-02213" class="usa-link">Supplementary Materials, Table S2</a>). In compounds <strong>1</strong> and <strong>3</strong>–<strong>6</strong>, iodine substituents are activated as XB donors due to the EWG effect exerted by the tetrachlorinated heteroaromatic scaffold, with <em>V</em><sub>S,max</sub> values ranging from 133.42 to 167.06 kJ/mol (<a href="#app1-molecules-25-02213" class="usa-link">Table S1</a>). In this regard, it is worth mentioning that in our previous studies [<a href="#B48-molecules-25-02213" class="usa-link" aria-describedby="B48-molecules-25-02213">48</a>,<a href="#B49-molecules-25-02213" class="usa-link" aria-describedby="B49-molecules-25-02213">49</a>,<a href="#B50-molecules-25-02213" class="usa-link" aria-describedby="B50-molecules-25-02213">50</a>,<a href="#B51-molecules-25-02213" class="usa-link" aria-describedby="B51-molecules-25-02213">51</a>,<a href="#B52-molecules-25-02213" class="usa-link" aria-describedby="B52-molecules-25-02213">52</a>,<a href="#B59-molecules-25-02213" class="usa-link" aria-describedby="B59-molecules-25-02213">59</a>], the function of compounds <strong>1</strong>–<strong>5</strong> as XB donors was demonstrated by theoretical calculations, and HPLC, NMR, and X-ray diffraction (XRD) analysis involving oxygen and nitrogen as XB acceptors. On the other hand, iodine is able to fill the hBPs better than other halogens due to its volume, so optimizing the strength of van der Waals interactions [<a href="#B42-molecules-25-02213" class="usa-link" aria-describedby="B42-molecules-25-02213">42</a>];</p>
</li>
<li>
<span class="label">(vi)</span><p class="display-inline">In compounds <strong>2</strong>–<strong>6</strong>, the chlorine substituents could also function as potential XB donors, even if lower <em>V</em><sub>S,max</sub> values ranging from 70.96 to 98.81 kJ/mol were calculated (<a href="#app1-molecules-25-02213" class="usa-link">Supplementary Materials, Table S1</a>) due to the lower polarizability and the higher electronegativity of chlorine with respect to iodine. Moreover, COX-1 being characterized by smaller hydrophobic binding pockets with respect to TTR [<a href="#B34-molecules-25-02213" class="usa-link" aria-describedby="B34-molecules-25-02213">34</a>,<a href="#B35-molecules-25-02213" class="usa-link" aria-describedby="B35-molecules-25-02213">35</a>], the presence of bulkier chlorines, with respect to hydrogens, might reduce binding affinity of the small molecule towards COX-1, thus increasing selectivity in TTR binding;</p>
</li>
<li>
<span class="label">(vii)</span><p class="display-inline">Since compounds <strong>3</strong>–<strong>5</strong> contain the same type and number of halogenated substituents but a different substitution pattern, it is possible to evaluate the scaffold effect on iodine properties and activity. Recently, Boeckler and co-workers demonstrated by theoretical calculations that the attachment position of a halogen within a heteroaromatic scaffold can influence size and shape of the σ-hole and, in turn, the strength of the XB [<a href="#B56-molecules-25-02213" class="usa-link" aria-describedby="B56-molecules-25-02213">56</a>];</p>
</li>
<li>
<span class="label">(viii)</span><p class="display-inline">All haogens can also act as hydrophobic sites and HB acceptors due to a belt of higher electron density located around the σ-hole (<a href="#molecules-25-02213-f004" class="usa-link">Figure 4</a>a).</p>
</li>
</ul></section><section id="sec2dot1dot2-molecules-25-02213"><h4 class="pmc_sec_title">2.1.2. Molecular Docking of Polyhalogenated 4,4′-Bipyridines <strong>1</strong>–<strong>6</strong> in the TTR Tetramer </h4>
<p>Molecular docking is one of the most popular computational approaches in structure-based drug design [<a href="#B60-molecules-25-02213" class="usa-link" aria-describedby="B60-molecules-25-02213">60</a>]. This technique can be used either to identify the correct conformation of the ligand within the target binding pocket or to estimate the interaction energy between a target and a ligand [<a href="#B61-molecules-25-02213" class="usa-link" aria-describedby="B61-molecules-25-02213">61</a>,<a href="#B62-molecules-25-02213" class="usa-link" aria-describedby="B62-molecules-25-02213">62</a>]. Molecular dynamics (MD) simulations can be also advantageously used to evaluate the molecular flexibility of ligands and receptors [<a href="#B63-molecules-25-02213" class="usa-link" aria-describedby="B63-molecules-25-02213">63</a>]. However, as some conformational changes occur in the time scale of only dozens of nanoseconds, this aspect could compromise the MD simulation viability for virtual screening studies. Moreover, computational cost of MD simulations is generally high. Therefore, a useful theoretical strategy is to select promising conformations from the docking study. In this regard, it is worth mentioning that different programs and theoretical methods are available for docking purposes, and each docking program shows advantages and limitations to carry out docking studies and docking-based virtual screening [<a href="#B64-molecules-25-02213" class="usa-link" aria-describedby="B64-molecules-25-02213">64</a>,<a href="#B65-molecules-25-02213" class="usa-link" aria-describedby="B65-molecules-25-02213">65</a>,<a href="#B66-molecules-25-02213" class="usa-link" aria-describedby="B66-molecules-25-02213">66</a>,<a href="#B67-molecules-25-02213" class="usa-link" aria-describedby="B67-molecules-25-02213">67</a>]. On the other hand, Hou and co-worker recently illustrated that no single docking program has dominative advantages than other programs [<a href="#B60-molecules-25-02213" class="usa-link" aria-describedby="B60-molecules-25-02213">60</a>,<a href="#B67-molecules-25-02213" class="usa-link" aria-describedby="B67-molecules-25-02213">67</a>]. Herein, due to the novelty of the 4,4′-bipyridyl motif in this field, a blind docking [<a href="#B21-molecules-25-02213" class="usa-link" aria-describedby="B21-molecules-25-02213">21</a>] exploration was performed in order to inspect the disposition of all enantiomers (<em>M</em>) and (<em>P</em>) of compounds <strong>1</strong>–<strong>5</strong> and the achiral <strong>6</strong> into the whole TTR, focusing on the binding capability toward the T<sub>4</sub> pockets. Despite the fact that flexible docking is frequently used to model ligand-receptor complexes accounting for molecular flexibility [<a href="#B64-molecules-25-02213" class="usa-link" aria-describedby="B64-molecules-25-02213">64</a>,<a href="#B65-molecules-25-02213" class="usa-link" aria-describedby="B65-molecules-25-02213">65</a>], we do not consider protein flexibility herein, rather focusing on the capability of the new compounds to insert in the same T<sub>4</sub> binding cavity hosting T<sub>4</sub>, as derived from the selected crystal complex. For this purpose, the released crystal structure of TTR complex (PDB ID: 1ICT, chains ABCD) [<a href="#B2-molecules-25-02213" class="usa-link" aria-describedby="B2-molecules-25-02213">2</a>] from the RCSB protein databank (<a href="http://www.rcbs.org" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">www.rcbs.org</a>) was used. AutoDock 4.2.6 was employed as docking program [<a href="#B68-molecules-25-02213" class="usa-link" aria-describedby="B68-molecules-25-02213">68</a>,<a href="#B69-molecules-25-02213" class="usa-link" aria-describedby="B69-molecules-25-02213">69</a>], and the software Chimera 1.13.1 [<a href="#B70-molecules-25-02213" class="usa-link" aria-describedby="B70-molecules-25-02213">70</a>] for the graphical representation of the poses derived from the docking calculation. Moreover, due to the atropisomeric features of the selected compounds, ligand flexibility is rather limited in this case. With the aim to assess the electrophilic behaviour of the halogens, the extra point [<a href="#B71-molecules-25-02213" class="usa-link" aria-describedby="B71-molecules-25-02213">71</a>,<a href="#B72-molecules-25-02213" class="usa-link" aria-describedby="B72-molecules-25-02213">72</a>] or explicit σ-hole (ESH) (<a href="#app1-molecules-25-02213" class="usa-link">Supplementary Materials, Table S7</a>) [<a href="#B73-molecules-25-02213" class="usa-link" aria-describedby="B73-molecules-25-02213">73</a>,<a href="#B74-molecules-25-02213" class="usa-link" aria-describedby="B74-molecules-25-02213">74</a>] concept was used to model the XB [<a href="#B51-molecules-25-02213" class="usa-link" aria-describedby="B51-molecules-25-02213">51</a>] in TTR/4,4′-bipyridine complexes. In the context of drug design, the use of the ESH correction to model XB in drug-receptor or drug-enzyme interactions has been recently reported [<a href="#B75-molecules-25-02213" class="usa-link" aria-describedby="B75-molecules-25-02213">75</a>]. </p>
<p>For both enantiomers of <strong>1</strong>, (<em>P</em>)-<strong>4</strong> and (<em>M</em>)-<strong>5</strong>, all poses laid outside the T<sub>4</sub> binding pockets, and on the surface of only one monomer. 4,4′-Bipyridines <strong>2</strong>, <strong>3</strong>, <strong>6</strong> and the enantiomers (<em>M</em>)-<strong>4</strong> and (<em>P</em>)-<strong>5</strong> were found in the T<sub>4</sub> pockets with docking score percentages lower than 21% and binding energy ranging from −6.14 to −4.93 kcal/mol. In particular, among all sites emerged from the blind docking procedure, the T<sub>4</sub> pockets were found to be the lowest energy sites for all compounds (<a href="#app1-molecules-25-02213" class="usa-link">Supplementary Materials, Table S8</a>). By comparing the clustering of the docking poses of the (<em>M</em>) series, it could be observed a clear preference of <strong>3</strong> for the T<sub>4</sub> pockets compared to compounds <strong>4</strong> and <strong>5</strong> (<a href="#molecules-25-02213-f005" class="usa-link">Figure 5</a>a). Indeed, 21% of docking poses of (<em>M</em>)-<strong>3</strong> laid inside the T<sub>4</sub> binding pockets, whereas lower percentages resulted for <strong>2</strong> and <strong>4</strong> (8% and 5%, respectively), these poses anchoring the side chains of the amino acid residues which identify the three hBPs (<a href="#app1-molecules-25-02213" class="usa-link">Supplementary Materials, Table S8 and Figure S2</a>). The lowest binding energy values (<a href="#molecules-25-02213-f005" class="usa-link">Figure 5</a>b) were observed for all poses of compounds <strong>3</strong> and <strong>6</strong> in the T<sub>4</sub> pockets, thus the 3,3′,5,5′-tetrachloro-2-iodo-4,4′-bipyridine motif showed higher binding capability for the T<sub>4</sub> pocket with respect to the other halogenated scaffolds. With the aim to confirm the docking results, all compounds <strong>1</strong>–<strong>6</strong> were tested in a first series of TTR FF assays.</p>
<figure class="fig xbox font-sm" id="molecules-25-02213-f005"><h5 class="obj_head">Figure 5.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=7248964_molecules-25-02213-g005.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4224/7248964/4823336865ff/molecules-25-02213-g005.jpg" loading="lazy" height="478" width="768" alt="Figure 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/molecules-25-02213-f005/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(<strong>a</strong>) Blind docking scores for the enantiomers of compounds <strong>1</strong>–<strong>5</strong> and the achiral <strong>6</strong> in the T<sub>4</sub> pockets; (<strong>b</strong>) docking score and binding energies of each pose of <strong>1</strong>–<strong>6</strong> laying in the T<sub>4</sub> pockets.</p></figcaption></figure></section><section id="sec2dot1dot3-molecules-25-02213"><h4 class="pmc_sec_title">2.1.3. Acid-Mediated TTR FF Assay for Compounds <strong>1</strong>–<strong>6</strong> and Structure-Activity Relationships</h4>
<p>Simulating the conditions found in the lysosome, the treatment of transparent solutions of tetrameric TTR with acids induces FF and precipitation that can be observed in vitro [<a href="#B15-molecules-25-02213" class="usa-link" aria-describedby="B15-molecules-25-02213">15</a>]. As FF is proportional to the turbidity degree of the parent solution, the inhibition capability of small molecules tested as fibrillogenesis inhibitors can be derived from turbidimetry analysis [<a href="#B76-molecules-25-02213" class="usa-link" aria-describedby="B76-molecules-25-02213">76</a>]. On this basis, the enantiomers of compounds <strong>1</strong>–<strong>5</strong> and the 2-iodinated-4,4′-bipyridine <strong>6</strong> were tested in this acid-mediated TTR fibrillogenesis assay in order to evaluate their capability to inhibit FF and precipitation. Both WT- and the mutant Y78F-TTR [<a href="#B8-molecules-25-02213" class="usa-link" aria-describedby="B8-molecules-25-02213">8</a>,<a href="#B77-molecules-25-02213" class="usa-link" aria-describedby="B77-molecules-25-02213">77</a>] were used as assay proteins. Thus, the compounds under evaluation were first incubated for 30 min with TTR at neutral pH (36 °C). The pH was then lowered to give the maximal rate of FF for a given variant (4.4 for WT, 5.0 for Y78F), and the samples were incubated for 72 h at 36 °C. For each sample, the degree of FF was determined by comparing its turbidity at 400 nm to that of a sample of TTR without test compound. On this basis, FF percentage (FF%) characterizes compound activity. Thus, the capability of compounds <strong>1</strong>–<strong>6</strong> in terms of FF% are summarized in <a href="#molecules-25-02213-t001" class="usa-link">Table 1</a>. The assays were carried out at two inhibitor concentrations, namely 7.2 μM (TTR/inhibitor ratio 1:2) and 3.6 μM which is equal to the TTR concentration in plasma. diflunisal was used as the positive control, whereas TTR under acidic conditions, without inhibitor, was fixed as a negative control (100% FF mark). On this basis, 10% FF corresponds to a compound inhibiting 90% of TTR fibrillogenesis.</p>
<section class="tw xbox font-sm" id="molecules-25-02213-t001"><h5 class="obj_head">Table 1.</h5>
<div class="caption p"><p>Inhibition of WT- and Y78F-TTR amyloid fibril formation under acidic denaturation condition in the presence of diflunisal, pure enantiomers of derivatives <strong>1</strong>–<strong>5</strong>, and achiral <strong>6</strong>.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead>
<tr>
<th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Compound</th>
<th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">FF% <sup>1</sup> (WT-TTR)</th>
<th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">FF% <sup>1</sup> (Y78F-TTR)</th>
</tr>
<tr>
<th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.2 μM</th>
<th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.6 μM</th>
<th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.2 μM</th>
<th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.6 μM</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Diflunisal</td>
<td align="center" valign="middle" rowspan="1" colspan="1">6</td>
<td align="center" valign="middle" rowspan="1" colspan="1">18</td>
<td align="center" valign="middle" rowspan="1" colspan="1">18</td>
<td align="center" valign="middle" rowspan="1" colspan="1">43</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">(<em>M</em>)-<strong>1</strong>
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">99</td>
<td align="center" valign="middle" rowspan="1" colspan="1">100</td>
<td align="center" valign="middle" rowspan="1" colspan="1">100</td>
<td align="center" valign="middle" rowspan="1" colspan="1">100</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">(<em>P</em>)-<strong>1</strong>
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">100</td>
<td align="center" valign="middle" rowspan="1" colspan="1">100</td>
<td align="center" valign="middle" rowspan="1" colspan="1">100</td>
<td align="center" valign="middle" rowspan="1" colspan="1">100</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">(<em>M</em>)-<strong>2</strong>
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">93</td>
<td align="center" valign="middle" rowspan="1" colspan="1">98</td>
<td align="center" valign="middle" rowspan="1" colspan="1">89</td>
<td align="center" valign="middle" rowspan="1" colspan="1">94</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">(<em>P</em>)-<strong>2</strong>
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">95</td>
<td align="center" valign="middle" rowspan="1" colspan="1">97</td>
<td align="center" valign="middle" rowspan="1" colspan="1">87</td>
<td align="center" valign="middle" rowspan="1" colspan="1">93</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">(<em>M</em>)-<strong>3</strong>
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">94</td>
<td align="center" valign="middle" rowspan="1" colspan="1">94</td>
<td align="center" valign="middle" rowspan="1" colspan="1">72</td>
<td align="center" valign="middle" rowspan="1" colspan="1">62</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">(<em>P</em>)-<strong>3</strong>
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">96</td>
<td align="center" valign="middle" rowspan="1" colspan="1">100</td>
<td align="center" valign="middle" rowspan="1" colspan="1">85</td>
<td align="center" valign="middle" rowspan="1" colspan="1">87</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">(<em>M</em>)-<strong>4</strong>
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">96</td>
<td align="center" valign="middle" rowspan="1" colspan="1">97</td>
<td align="center" valign="middle" rowspan="1" colspan="1">87</td>
<td align="center" valign="middle" rowspan="1" colspan="1">91</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">(<em>P</em>)-<strong>4</strong>
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">96</td>
<td align="center" valign="middle" rowspan="1" colspan="1">99</td>
<td align="center" valign="middle" rowspan="1" colspan="1">95</td>
<td align="center" valign="middle" rowspan="1" colspan="1">95</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">(<em>M</em>)-<strong>5</strong>
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">90</td>
<td align="center" valign="middle" rowspan="1" colspan="1">97</td>
<td align="center" valign="middle" rowspan="1" colspan="1">85</td>
<td align="center" valign="middle" rowspan="1" colspan="1">91</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">(<em>P</em>)-<strong>5</strong>
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">98</td>
<td align="center" valign="middle" rowspan="1" colspan="1">98</td>
<td align="center" valign="middle" rowspan="1" colspan="1">100</td>
<td align="center" valign="middle" rowspan="1" colspan="1">94</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>6</strong>
</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">91</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">95</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">73</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">82</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/molecules-25-02213-t001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="fn2"><p><sup>1</sup> Fibril formation (FF)% represents the extent of amyloidogenic TTR FF in the presence of inhibitors (7.2 μM or 3.6 μM inhibitor, 3.6 μM TTR, pH 4.4 (WT) or 5.0 (Y78F), 36 °C, 72 h), compared to untreated TTR (100% fibril formation). The experiments were performed in triplicate and the average values are reported in the Table. The standard deviations were in the range 5–10.</p></div></div></section><p>With WT-TTR, high degree of fibrillogenesis was observed for compounds <strong>1</strong>–<strong>6</strong> with FF% ranging from 90 to 100%, whereas with the mutant variant Y78F slightly lower values were found in almost all cases. In accord with the docking evaluations, in general the (<em>M</em>)-enantiomers were found to be slightly more effective than the (<em>P</em>)-enantiomers, whereas both enantiomers of compound <strong>1</strong> showed no inhibition activity against fibrillogenesis. Interestingly, compounds (<em>M</em>)-<strong>3</strong> and <strong>6</strong> proved to be the best inhibitors against Y78F-TTR fibrillogenesis with values ranging from 62 to 82%.</p>
<p>Compounds <strong>1</strong>–<strong>6</strong> were also docked in the T<sub>4</sub> pocket at the BD interface in order to derive the respective estimated free energy of binding (EFEB) (<a href="#app1-molecules-25-02213" class="usa-link">Supplementary Materials, Table S9</a>). The crystallographic T<sub>4</sub> structure [<a href="#B2-molecules-25-02213" class="usa-link" aria-describedby="B2-molecules-25-02213">2</a>] was used as benchmark ligand to validate the docking procedure (<a href="#app1-molecules-25-02213" class="usa-link">Supplementary Materials, Figure S3</a>). The predictive success of the EFEB values was verified by linear regression. </p>
<p>For enantiomers <strong>1</strong>–<strong>5</strong> and compound <strong>6</strong>, the results of fitting a simple linear regression model to describe the relationship between FF% and EFEB, as an independent variable, is reported in <a href="#molecules-25-02213-f006" class="usa-link">Figure 6</a> for Y78F at 7.2 μM (<a href="#app1-molecules-25-02213" class="usa-link">Supplementary Materials, Figure S4</a> for the plots of WT-TTR and Y78F at 3.6 μM). In all cases, the <em>P</em>-values of the considered independent variable are lower than the statistical benchmark value of 0.05.</p>
<figure class="fig xbox font-sm" id="molecules-25-02213-f006"><h5 class="obj_head">Figure 6.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=7248964_molecules-25-02213-g006.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4224/7248964/508fb7173dbb/molecules-25-02213-g006.jpg" loading="lazy" height="417" width="732" alt="Figure 6"></a></p>
<div class="p text-right font-secondary"><a href="figure/molecules-25-02213-f006/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Linear regression analysis describing the relationships between FF% (Y78F-TTR, inhibitor concentration = 7.2 μM) and calculated EFEB by docking in the T<sub>4</sub> pocket (BD).</p></figcaption></figure><p>It is worth mentioning that no statistical correlation was found between FF% and the EFEB values calculated without the application of the ESH parametrization for halogens (0.1199 ≤ <em>P</em>-value ≤ 0.9871).</p>
<p>The complete inactivity of compound <strong>1</strong> could be related to the six bulky iodine substituents which prevent the accommodation of the molecule in the T<sub>4</sub> pocket. From a comparative analysis of the structure-activity relationships, it seems that the presence of iodine substituents at positions 3,3′,5,5′ (compounds <strong>1</strong>, <strong>4</strong>, <strong>5</strong>) is detrimental for both binding and inhibition activity, whereas 2- and 2′-iodine substitutions exhibit a beneficial effect on 4,4′-bipyridine activity.</p>
<p>From these results, the 3,3′,5,5′-tetrachloro-2-iodo-4,4′-bipyridyl substructure (iodine <em>V</em><sub>S,max</sub> values: 140.8 kJ/mol for <strong>3</strong>, 136.8 kJ/mol for <strong>6</strong>) has been identified as the most interesting scaffold for elaborating more specific compounds. On this basis, compounds <strong>7</strong>–<strong>10</strong> were prepared by focused procedures to introduce a phenyl, a 4-pyridyl, a 4-hydroxyphenyl and a hydroxymethyl as a 2′-substituent, respectively. These substituents were selected to probe how subtle structural changes at position 2′ can influence the inhibition activity.</p></section></section><section id="sec2dot2-molecules-25-02213"><h3 class="pmc_sec_title">2.2. Chemistry</h3>
<section id="sec2dot2dot1-molecules-25-02213"><h4 class="pmc_sec_title">2.2.1. Syntheses of 4,4′-Bipyridines <strong>1</strong>–<strong>10</strong>
</h4>
<p>The synthesis of chiral hexahalogenated 4,4′-bipyridines <strong>1</strong>–<strong>5</strong> was previously reported by our groups, exploiting convergent or divergent strategies depending on halogen type and position on the heteroaromatic scaffold [<a href="#B47-molecules-25-02213" class="usa-link" aria-describedby="B47-molecules-25-02213">47</a>,<a href="#B48-molecules-25-02213" class="usa-link" aria-describedby="B48-molecules-25-02213">48</a>]. These methodologies proved to be extremely versatile and allowed to introduce Cl, Br, and I at any position of the 4,4′-bipyridyl scaffold [<a href="#B48-molecules-25-02213" class="usa-link" aria-describedby="B48-molecules-25-02213">48</a>].</p>
<p>3,3′,5,5′-Tetrachloro-2,2′-diiodo-4,4′-bipyridine (<strong>3</strong>) was prepared in two steps from the commercially available 2-bromo-3,5-dichloropyridine (<strong>11</strong>). First, a lithium diisopropylamide (LDA)-mediated dimerization afforded 3,3′,5,5′-tetrachloro-2,2′-dibromo-4,4′-bipyridine (<strong>12</strong>), and then the bromine atoms in 2,2′-positions were exchanged for iodines through a diaminocopper-catalyzed Finkelstein reaction. Along with the expected 4,4′-bipyridine <strong>3</strong>, careful chromatographic purification allowed obtaining in small quantity the 3,3′,5,5′-tetrachloro-2-iodo- 4,4′-bipyridine <strong>6</strong> (<a href="#molecules-25-02213-sch001" class="usa-link">Scheme 1</a>).</p>
<figure class="fig xbox font-sm" id="molecules-25-02213-sch001"><h5 class="obj_head">Scheme 1.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=7248964_molecules-25-02213-sch001.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4224/7248964/69518633fb40/molecules-25-02213-sch001.jpg" loading="lazy" height="658" width="756" alt="Scheme 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/molecules-25-02213-sch001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Synthesis of bipyridines <strong>6</strong>–<strong>10</strong>.</p></figcaption></figure><p>For 4,4′-bipyridines <strong>7</strong>–<strong>9</strong>, the aromatic ring in 2-position was introduced through a Suzuki coupling reaction involving 4,4′-bipyridine <strong>3</strong> and one equivalent of the respective boronic acid <strong>13</strong>. The use of phenyl- and 4-pyridylboronic acids <strong>13a,b</strong> afforded 3,3′,5,5′-tetrachloro-2-iodo-2′-phenyl-4,4′-bipyridine (<strong>7</strong>) and 3,3′,5,5′-tetrachloro-2-iodo-2′-(4- pyridyl)-4,4′-bipyridine (<strong>8</strong>), respectively.</p>
<p>The direct synthesis of the 3,3′,5,5′-tetrachloro-2-iodo-2′-(4-hydroxyphenyl)-4,4′-bipyridine (<strong>9</strong>) by coupling of <strong>3</strong> with 4-hydroxyphenylboronic acid (<strong>13c</strong>) failed under Suzuki coupling conditions. Therefore, compound <strong>9</strong> was obtained in two steps by using the <em>tert</em>-butyldimethylsilyl (TBS)-protected 4-hydroxyphenylboronic acid <strong>13d</strong>. After the cross-coupling reaction between compounds <strong>3</strong> and <strong>13d</strong>, 3,3′,5,5′-tetrachloro-2-iodo-2′-(4-<em>tert</em>-butyldimethylsilyloxyphenyl)- 4,4′-bipyridine (<strong>14</strong>) was isolated, and the TBS-protecting group was subsequently removed by using a tetrahydrofuran solution of tetrabutylammonium fluoride (<em>n</em>-Bu<sub>4</sub>NF), affording 4,4′-bipyridine <strong>9</strong>. Finally, 3,3′,5,5′-tetrachloro-2-iodo-2′-hydroxymethyl-4,4′-bipyridine (<strong>10</strong>) was obtained in a one-pot two-step process starting from 4,4′-bipyridine <strong>3</strong>. After iodine-lithium exchange with one equivalent of <em>n</em>-butyllithium (<em>n</em>-BuLi) in toluene, the lithiated species was quenched with dimethylformamide (DMF) to give the aldehyde intermediate <strong>15</strong> which was directly reduced with sodium borohydride (NaBH<sub>4</sub>) to afford bipyridine <strong>10</strong>.</p></section><section id="sec2dot2dot2-molecules-25-02213"><h4 class="pmc_sec_title">2.2.2. Enantioseparation of 4,4′-Bipyridines <strong>7–10</strong> on Chiral Stationary Phases</h4>
<p><em>Rac</em>-4,4′-bipyridines <strong>1</strong>–<strong>5</strong> were enantioseparated at multimilligram scale on polysaccharide- based chiral stationary phases, as previously reported by our groups [<a href="#B48-molecules-25-02213" class="usa-link" aria-describedby="B48-molecules-25-02213">48</a>,<a href="#B59-molecules-25-02213" class="usa-link" aria-describedby="B59-molecules-25-02213">59</a>]. Pure enantiomers (&gt;95% ee) of 3,3′,5,5′-tetrachloro-2-iodo-2′-substituted-4,4′-bipyridines <strong>7</strong>–<strong>10</strong> were obtained in good amounts by means of HPLC multimilligram enantioseparation under normal phase elution conditions (<a href="#app1-molecules-25-02213" class="usa-link">Supplementary Materials, Table S10</a>). In particular, the enantiomers of compounds <strong>7</strong> and <strong>9</strong> were recovered by using Chiralpak IA (immobilized amylose tris(3,5-dimethyl- phenylcarbamate)) as a chiral column, whereas the Chiralcel OD-H (cellulose tris(3,5-dimethylphenylcarbamate)) was used for the enantioseparations of compounds <strong>8</strong> and <strong>10</strong>. Recorded in ethanol, the ECD spectra of the four enantiomer pairs <strong>7</strong>–<strong>10</strong> showed the expected opposite traces for the two atropisomers (<a href="#app1-molecules-25-02213" class="usa-link">Supplementary Materials, Figures S21–S24</a>).</p></section><section id="sec2dot2dot3-molecules-25-02213"><h4 class="pmc_sec_title">2.2.3. Absolute Configuration Assignment of <strong>7</strong>–<strong>10</strong>
</h4>
<p>The absolute configuration of HPLC-separated enantiomers of bipyridines <strong>1</strong> and <strong>2</strong> was previously assigned through XRD analysis by using the anomalous dispersion of heavy atoms [<a href="#B48-molecules-25-02213" class="usa-link" aria-describedby="B48-molecules-25-02213">48</a>,<a href="#B59-molecules-25-02213" class="usa-link" aria-describedby="B59-molecules-25-02213">59</a>]. However, for the enantiomers of bipyridines <strong>3</strong>–<strong>5</strong>, which could not be crystallized, the absolute configuration was determined by electronic circular dichroism (ECD) coupled with time-dependent density functional theory (TD-DFT) calculations [<a href="#B59-molecules-25-02213" class="usa-link" aria-describedby="B59-molecules-25-02213">59</a>]. Analogously, the absolute configurations assignment of enantiomers of the newly synthesized bipyridines <strong>7</strong>–<strong>10</strong> was performed by comparing the measured ECD spectra with the ones calculated by TD-DFT. The calculation of the ECD spectra was performed considering all the possible conformers arising from the rotation of the substituent in 2′-position with respect to the pyridine ring [<a href="#B78-molecules-25-02213" class="usa-link" aria-describedby="B78-molecules-25-02213">78</a>] (see <a href="#app1-molecules-25-02213" class="usa-link">Supplementary Materials, S6</a> for details). For each compound, except a systematic shift of about 15 nm between the measured and calculated spectra [<a href="#B50-molecules-25-02213" class="usa-link" aria-describedby="B50-molecules-25-02213">50</a>,<a href="#B78-molecules-25-02213" class="usa-link" aria-describedby="B78-molecules-25-02213">78</a>], a very good match was obtained allowing unambiguous absolute configuration assignment of all enantiomers (<a href="#app1-molecules-25-02213" class="usa-link">Supplementary Materials, Table S10 and Figures S25–S28</a>).</p></section></section><section id="sec2dot3-molecules-25-02213"><h3 class="pmc_sec_title">2.3. Biological Evaluation of Compounds <strong><em>7–10</em></strong> and Structure-Activity Relationships </h3>
<p>The enantiomers of compounds <strong>7</strong>–<strong>10</strong> were tested by using the acid-mediated TTR FF assays described above, in order to evaluate their capability to inhibit fibrillogenesis as soluble TTR is treated with acidic medium. WT- and the mutants Y78F- [<a href="#B8-molecules-25-02213" class="usa-link" aria-describedby="B8-molecules-25-02213">8</a>], and V30M-TTR [<a href="#B7-molecules-25-02213" class="usa-link" aria-describedby="B7-molecules-25-02213">7</a>] were used as assay proteins, whose stability order is WT &gt; V30M &gt; Y78F [<a href="#B7-molecules-25-02213" class="usa-link" aria-describedby="B7-molecules-25-02213">7</a>,<a href="#B8-molecules-25-02213" class="usa-link" aria-describedby="B8-molecules-25-02213">8</a>]. The results are reported in <a href="#molecules-25-02213-t002" class="usa-link">Table 2</a>.</p>
<section class="tw xbox font-sm" id="molecules-25-02213-t002"><h4 class="obj_head">Table 2.</h4>
<div class="caption p"><p>Inhibition of WT-, Y78F-, and V30M-TTR amyloid fibril formation under acidic denaturation condition in the presence of diflunisal, and pure enantiomers of derivatives <strong>7</strong>–<strong>10</strong>.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead>
<tr>
<th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Compound</th>
<th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">FF% <sup>1</sup> (WT-TTR)</th>
<th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">FF% <sup>1</sup> (Y78F-TTR)</th>
<th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">FF%<sup>1</sup> (V30M-TTR)</th>
</tr>
<tr>
<th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.2 μM</th>
<th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.6 μM</th>
<th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.2 μM</th>
<th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.6 μM</th>
<th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.2 μM</th>
<th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.6 μM</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Diflunisal</td>
<td align="center" valign="middle" rowspan="1" colspan="1">6</td>
<td align="center" valign="middle" rowspan="1" colspan="1">18</td>
<td align="center" valign="middle" rowspan="1" colspan="1">18</td>
<td align="center" valign="middle" rowspan="1" colspan="1">43</td>
<td align="center" valign="middle" rowspan="1" colspan="1">36</td>
<td align="center" valign="middle" rowspan="1" colspan="1">33</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">(<em>M</em>)-<strong>7</strong>
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">96</td>
<td align="center" valign="middle" rowspan="1" colspan="1">100</td>
<td align="center" valign="middle" rowspan="1" colspan="1">82</td>
<td align="center" valign="middle" rowspan="1" colspan="1">84</td>
<td align="center" valign="middle" rowspan="1" colspan="1">nd</td>
<td align="center" valign="middle" rowspan="1" colspan="1">nd</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">(<em>P</em>)-<strong>7</strong>
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">88</td>
<td align="center" valign="middle" rowspan="1" colspan="1">95</td>
<td align="center" valign="middle" rowspan="1" colspan="1">71</td>
<td align="center" valign="middle" rowspan="1" colspan="1">88</td>
<td align="center" valign="middle" rowspan="1" colspan="1">nd</td>
<td align="center" valign="middle" rowspan="1" colspan="1">nd</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">(<em>M</em>)-<strong>8</strong>
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">58</td>
<td align="center" valign="middle" rowspan="1" colspan="1">72</td>
<td align="center" valign="middle" rowspan="1" colspan="1">79</td>
<td align="center" valign="middle" rowspan="1" colspan="1">82</td>
<td align="center" valign="middle" rowspan="1" colspan="1">50</td>
<td align="center" valign="middle" rowspan="1" colspan="1">58</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">(<em>P</em>)-<strong>8</strong>
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">42</td>
<td align="center" valign="middle" rowspan="1" colspan="1">67</td>
<td align="center" valign="middle" rowspan="1" colspan="1">51</td>
<td align="center" valign="middle" rowspan="1" colspan="1">67</td>
<td align="center" valign="middle" rowspan="1" colspan="1">38</td>
<td align="center" valign="middle" rowspan="1" colspan="1">43</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">(<em>M</em>)-<strong>9</strong>
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">16</td>
<td align="center" valign="middle" rowspan="1" colspan="1">49</td>
<td align="center" valign="middle" rowspan="1" colspan="1">44</td>
<td align="center" valign="middle" rowspan="1" colspan="1">71</td>
<td align="center" valign="middle" rowspan="1" colspan="1">38</td>
<td align="center" valign="middle" rowspan="1" colspan="1">40</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">(<em>P</em>)-<strong>9</strong>
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">17</td>
<td align="center" valign="middle" rowspan="1" colspan="1">49</td>
<td align="center" valign="middle" rowspan="1" colspan="1">44</td>
<td align="center" valign="middle" rowspan="1" colspan="1">72</td>
<td align="center" valign="middle" rowspan="1" colspan="1">39</td>
<td align="center" valign="middle" rowspan="1" colspan="1">41</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">(<em>M</em>)-<strong>10</strong>
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">62</td>
<td align="center" valign="middle" rowspan="1" colspan="1">79</td>
<td align="center" valign="middle" rowspan="1" colspan="1">80</td>
<td align="center" valign="middle" rowspan="1" colspan="1">88</td>
<td align="center" valign="middle" rowspan="1" colspan="1">59</td>
<td align="center" valign="middle" rowspan="1" colspan="1">75</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(<em>P</em>)-<strong>10</strong>
</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">80</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">89</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">85</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">91</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">67</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">72</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/molecules-25-02213-t002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="fn3"><p><sup>1</sup> Fibril formation (FF)% represents the extent of amyloidogenic TTR FF in the presence of inhibitors (7.2 μM or 3.6 μM inhibitor, 3.6 μM TTR, pH 4.4 (WT) or 5.0 (V30M and Y78F), 36 °C, 72 h), compared to untreated TTR (100% fibril formation). The experiments were performed in triplicate and the average values are reported in the Table. The standard deviations were in the range 5–10; nd, not determined.</p></div></div></section><p>Among the three TTR forms, the FF% values were higher against V30M and Y78F than WT-TTR. On the basis of the turbidimetric assay results, the inhibition activity trend was shown to be <strong>9</strong> &gt; <strong>8</strong> &gt; <strong>10</strong> &gt; <strong>7</strong>, with few exceptions. Again, the (<em>M</em>) enantiomers were found to be more active than the (<em>P</em>)-enantiomers for compounds <strong>9</strong> and <strong>10</strong>, whereas the (<em>P</em>)-enantiomers proved to be more effective for <strong>7</strong> and <strong>8</strong>. For both enantiomers of compound <strong>9</strong>, amyloid fibrillogenesis was significantly suppressed on WT-TTR at 7.2 μM of inhibitor concentration (FF% 16 and 17). Both (<em>M</em>)-<strong>9</strong> and (<em>P</em>)-<strong>9</strong> were also tested at different concentrations ranging from 0 to 15 μM using diflunisal for comparison (<a href="#app1-molecules-25-02213" class="usa-link">Supplementary Information, Figure S29</a>). As reported for other known TTR stabilizers, compound <strong>9</strong> dose-dependently inhibited WT-TTR amyloidogenesis.</p>
<p>Structure-activity relationships revealed that a HB centre on one pyridyl ring contributes to increase the inhibition activity, moderately for compounds <strong>8</strong> and <strong>10</strong>, more for compound <strong>9</strong>. In compound <strong>7</strong>, the presence of the hydrophobic phenyl, as distinctive substituent, appears to be detrimental for the inhibition activity. Molecular docking carried out targeting the T<sub>4</sub> pocket showed that compounds <strong>7</strong>–<strong>10</strong> could be accommodated in the hormone-binding site. Focusing on the four (<em>M</em>)-enantiomers, the following observations emerged (<a href="#molecules-25-02213-f007" class="usa-link">Figure 7</a>):</p>
<ul class="list" style="list-style-type:none">
<li>
<span class="label">(i)</span><p class="display-inline">Compound (<em>M</em>)-<strong>9</strong> (<a href="#molecules-25-02213-f007" class="usa-link">Figure 7</a>a) fully occupies the T<sub>4</sub> pocket (molecular length 13.2 Å, <em>V</em><sub>S</sub> isosurface enclosed volume 367.0 Å<sup>3</sup>), where the 4-hydroxyphenyl group is oriented toward B:Thr<sub>106</sub> and B:Val<sub>121</sub> (hBP<sub>1</sub>) and the four chlorines at the 3,3,5,5′-positions of the heteroaromatic ring anchor the residues B:Ala<sub>108</sub> and D:Ala<sub>108’</sub> (hBP<sub>2</sub>). Moreover, the <em>N</em>’<sub>pyr</sub> (<em>V</em><sub>S,min</sub> = -128.3 kJ/mol) forms a HB with the ε-ammonium group of D:Lys<sub>15’</sub> (2.6 Å), and 2-iodine (<em>V</em><sub>S,max</sub> = 129.8 kJ/mol) showed a short contact with the side chain oxygen of D:Ser<sub>117’’</sub> (3.2 Å) (hBP<sub>3</sub>). Interestingly, the comparison of the respective <em>V</em><sub>S</sub> isosurface evidences for compound <strong>9</strong> a shape similarity to both T<sub>4</sub> and tafamidis (<a href="#app1-molecules-25-02213" class="usa-link">Supplementary Information, Figure S1</a>);</p>
</li>
<li>
<span class="label">(ii)</span><p class="display-inline">Compound <strong>10</strong> (<a href="#molecules-25-02213-f007" class="usa-link">Figure 7</a>b) is the smallest molecule of the series with a molecular length of about 9.80 Å and a volume of 303.1 Å<sup>3</sup>, therefore it is not able to fully occupy the T<sub>4</sub> pocket, 2-iodine showing a longer contact with B:Ser<sub>117</sub> (4.4 Å) despite a positive <em>V</em><sub>S,max</sub> value (141.6 kJ/mol). Moreover, the best conformation of compound <strong>10</strong> is characterized by an intramolecular HB involving the hydroxyl group and N’<sub>pyr</sub> (<em>V</em><sub>S,min</sub> = −29.12 kJ/mol). The latter is therefore less prone to interact with the side chain of D:Lys<sub>15’</sub>;</p>
</li>
<li>
<span class="label">(iii)</span><p class="display-inline">For both compounds <strong>7</strong> and <strong>8</strong> (<a href="#molecules-25-02213-f007" class="usa-link">Figure 7</a>c), reverse binding modes were found by molecular docking, with the N<sub>pyr</sub> interacting with D:Lys<sub>15’</sub> in all cases. The basic difference between the two compounds, which could justify the different inhibition activity, lies in the presence of a N<sub>pyr</sub>, as a HB acceptor, at the 2′-position of compound <strong>8</strong> which makes possible an interaction with B:Ser<sub>117</sub>, thus anchoring the two monomers B and D.</p>
</li>
</ul>
<figure class="fig xbox font-sm" id="molecules-25-02213-f007"><h4 class="obj_head">Figure 7.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=7248964_molecules-25-02213-g007.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4224/7248964/3fa1fad1f14f/molecules-25-02213-g007.jpg" loading="lazy" height="284" width="800" alt="Figure 7"></a></p>
<div class="p text-right font-secondary"><a href="figure/molecules-25-02213-f007/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Docking modes into the T<sub>4</sub> binding pocket (BD) for the (<em>M</em>)-enantiomers of <strong>9</strong> (<strong>a</strong>), <strong>10</strong> (<strong>b</strong>) and the pair <strong>7</strong>/<strong>8</strong> (superimposed structures) (<strong>c</strong>).</p></figcaption></figure></section></section><section id="sec3-molecules-25-02213"><h2 class="pmc_sec_title">3. Materials and Methods</h2>
<section id="sec3dot1-molecules-25-02213"><h3 class="pmc_sec_title">3.1. Chemistry</h3>
<section id="sec3dot1dot1-molecules-25-02213"><h4 class="pmc_sec_title">3.1.1. General Information</h4>
<p>Proton (<sup>1</sup>H-NMR) and carbon (<sup>13</sup>C-NMR) nuclear magnetic resonance spectra were recorded on Bruker Avance III instruments operating at 500 MHz (Bruker Corporation, Billerica, MA, USA). The chemical shifts are given in parts per million (ppm) on the delta scale. The solvent peak was used as reference values for <sup>1</sup>H-NMR (CDCl<sub>3</sub> = 7.26 ppm) and for <sup>13</sup>C-NMR (CDCl<sub>3</sub> = 77.16 ppm). Data are presented as follows: chemical shift, multiplicity (s= singlet, d= doublet, t= triplet, q= quartet, quint= quintet, m= multiplet, b= broad), integration, and coupling constants (<em>J</em>/Hz). High-resolution mass spectra (HRMS) data were recorded on a Bruker micrOTOF spectrometer equipped with an orthogonal electrospray interface (ESI). Melting points were measured on Stuart SMP3 apparatus from Cole Parmer (London, UK) and are uncorrected. Analytical thin layer chromatography (TLC plates from Merck KGaA, Darmstadt, Germany) was carried out on silica gel 60 F254 plates with visualization by ultraviolet light. Reagents and solvents were purified using standard means. Tetrahydrofuran (THF) was distilled from sodium metal/benzophenone and stored under an argon atmosphere. Anhydrous reactions were carried out in flame-dried glassware and under an argon atmosphere. 2,2′,3,3′,5,5′-Hexaiodo-4,4′-bipyridine (<strong>1</strong>), 2,2′,3,3′,5,5′-hexachloro- 4,4′-bipyridine (<strong>2</strong>), 3,3′,5,5′-tetrachloro-2,2′-diiodo-4,4′-bipyridine (<strong>3</strong>), 2,2′,5,5′-tetrachloro-3,3′- diiodo-4,4′-bipyridine (<strong>4</strong>), 2,2′,3,3′-tetrachloro-5,5′-diiodo-4,4′-bipyridine (<strong>5</strong>) and 3,3′,5,5′-tetra- chloro-2,2′-dibromo-4,4′-bipyridine (<strong>12</strong>) were prepared according to the literature [<a href="#B48-molecules-25-02213" class="usa-link" aria-describedby="B48-molecules-25-02213">48</a>]. All other chemicals were used as received. CD spectra were recorded on a J-810 instrument from Jasco (JASCO International Co. Ltd., Tokyo, Japan) at room temperature using 0.15–0.30 mM samples in ethanol and a 1 mm quartz cell, with the following conditions: 100 nm/min scanning speed, 1 nm data pitch, 4.0 nm bandwidth, 1 s response time.</p></section><section id="sec3dot1dot2-molecules-25-02213"><h4 class="pmc_sec_title">3.1.2. Syntheses of 3,3′,5,5′-Tetrachloro-2,2′-diiodo-4,4′-bipyridine (<strong>3</strong>) and 3,3′,5,5′-tetrachloro-2-iodo- 4,4′-bipyridine (<strong>6</strong>)</h4>
<p>In a dry Schlenk tube were placed 2,2′-dibromo-tetrahalo-4,4′-bipyridine (800 mg, 1.77 mmol), NaI (1.06 g, 7.08 mmol), CuI (50 mg, 0.35 mmol), and (<em>rac</em>)-<em>trans</em>-<em>N</em>,<em>N</em>-dimethyl- cyclohexane-1,2-diamine (64 mg, 0.71 mmol). The Schlenk tube was evacuated and filled with argon before addition of degassed dioxane (5 mL). The mixture was heated at 120 °C for 60 h. After cooling to room temperature, NH<sub>4</sub>OH (7 mL) and H<sub>2</sub>O (8 mL) were added. Then, the product was extracted with dichloromethane (4 × 40 mL). After drying over Na<sub>2</sub>SO<sub>4</sub>, filtration, and concentration, the mixture was purified by chromatography on silica gel (pentane/dichloromethane 7/3) to give bipyridine <strong>3</strong> [<a href="#B48-molecules-25-02213" class="usa-link" aria-describedby="B48-molecules-25-02213">48</a>] (white powder, 733 mg, 76%, R<sub>f</sub> = 0.27) and bipyridine <strong>6</strong> (white powder, 126 mg, 17%, R<sub>f</sub> = 0.15). Mp: 126–127 °C; <sup>1</sup>H-NMR (500 MHz, CDCl<sub>3</sub>) δ 8.67 (s, 2H), 8.46 (s, 1H). <sup>13</sup>C-NMR (126 MHz, CDCl<sub>3</sub>) δ 148.0; 147.8; 140.6; 140.3; 137.3; 131.2; 130.9; 119.5. HRMS (ESI-TOF) [M + H]<sup>+</sup>
<em>m</em>/<em>z</em>: Calcd. for C<sub>10</sub>H<sub>3</sub>Cl<sub>4</sub>IN<sub>2</sub> 418.8168, found: 418.8152.</p></section><section id="sec3dot1dot3-molecules-25-02213"><h4 class="pmc_sec_title">3.1.3. General Procedure for the Synthesis of Bipyridines <strong>7</strong>, <strong>8</strong> and <strong>14</strong>
</h4>
<p>In a dry Schlenk tube were placed bipyridine <strong>6</strong> (0.28–0.72 mmol) and tetrakis(triphenylphosphine)palladium (10 mol%). The Schlenk tube was evacuated and filled with argon before addition of degassed toluene (2–5 mL). Then a boronic acid solution (1 eq.) in methanol (0.5–1.0 mL) was added and after 10 min of stirring, at room temperature, a sodium carbonate solution (2 eq.) in distilled water (0.5–1.0 mL) was added. The mixture was heated at 110 °C for 20 h. After cooling to room temperature, brine (10 mL) was added. Then, the product was extracted with dichloromethane (3 × 15 mL). After drying over Na<sub>2</sub>SO<sub>4</sub>, filtration, and concentration, the products were purified by chromatography on silica gel. </p>
<section id="sec17"><h5 class="pmc_sec_title">3,3′,5,5′-Tetrachloro-2-iodo-2′-phenyl-4,4′-bipyridine (7) </h5>
<p>Compound <strong>7</strong> was obtained as colorless solid (85 mg, 62%) using the following conditions: <strong>6</strong> (150 mg, 0.28 mmol), tetrakis(triphenylphosphine)palladium (32 mg, 0.028 mmol), phenylboronic acid (34 mg, 0.28 mmol), sodium carbonate (59 mg, 0.55 mmol). Chromatography on silica gel (cyclohexane/ethyl acetate 95/5). Mp: 105–106 °C; <sup>1</sup>H-NMR (500 MHz, CDCl<sub>3</sub>) δ 8.76 (s, 1H), 8.49 (s, 1H), 7.78–7.71 (m, 2H), 7.53–7.46 (m, 3H). <sup>13</sup>C-NMR (126 MHz, CDCl<sub>3</sub>) δ 156.2, 147.8, 147.5, 141.9, 141.3, 137.3, 137.1, 131.2, 129.6, 129.5, 129.1, 128.7, 128.4, 119.5. HRMS (ESI-TOF) [M + H]<sup>+</sup>
<em>m</em>/<em>z</em>: Calcd. for C<sub>16</sub>H<sub>8</sub>Cl<sub>4</sub>N<sub>2</sub> 495.8481, found: 494.8509.</p></section><section id="sec18"><h5 class="pmc_sec_title">3,3′,5,5′-Tetrachloro-2-iodo-2′-(4-pyridyl)-4,4′-bipyridine (8)</h5>
<p>Compound <strong>8</strong> was obtained as a viscous wax (49 mg, approx. 75% purity according to <sup>1</sup>H-NMR after chromatography on silica gel with eluent: cyclohexane/ethyl acetate/triethylamine 85/10/5) using the following conditions: <strong>6</strong> (150 mg, 0.28 mmol), tetrakis(triphenylphosphine)palladium (22 mg, 0.019 mmol), 4-pyridinylboronic acid (35 mg, 0.29 mmol), sodium carbonate (59 mg, 0.55 mmol). A pure sample (13.3 mg, 10% yield) was obtained after HPLC purification on a Chiralpak IA column (<em>n</em>-hexane/2-propanol 90:10, 0.8 mL/min). <sup>1</sup>H-NMR (500 MHz, CDCl<sub>3</sub>) δ 8.79 (m, 3H), 8.50 (s, 1H), 7.71 (d, <em>J</em> = 5.0 Hz, 2H). <sup>13</sup>C-NMR (126 MHz, CDCl<sub>3</sub>) δ 153.3, 150.1, 148.0, 147.9, 144.6, 142.4, 140.8, 137.2, 131.1, 130.7, 129.1, 124.0, 119.5. HRMS (ESI-TOF) [M + H]<sup>+</sup>
<em>m</em>/<em>z</em>: Calcd. for C<sub>15</sub>H<sub>7</sub>Cl<sub>4</sub>IN<sub>3</sub> 495.8433, found: 494.8400.</p></section><section id="sec19"><h5 class="pmc_sec_title">3,3′,5,5′-Tetrachloro-2-iodo-2′-(4-((tert-butyldimethylsilyl)oxy)phenyl)-4,4′-bipyridine (14) </h5>
<p>Compound <strong>14</strong> was obtained as viscous oil (199 mg, 44%) using the following conditions: <strong>6</strong> (324 mg, 0.72 mmol), tetrakis(triphenylphosphine)palladium (58 mg, 0.0150 mmol), 4-(<em>tert</em>-butyl- dimethylsilyloxy)-phenylboronic acid (190 mg, 0.753 mmol), sodium carbonate (152 mg, 1.43 mmol). Chromatography on silica gel (cyclohexane/ethyl acetate 95/5). <sup>1</sup>H-NMR (500 MHz, CDCl<sub>3</sub>) δ 8.72 (s, 1<em>H</em>), 8.48 (s, 1<em>H</em>), 7.68 (d, <em>J</em> = 8.7 Hz, 2H), 6.94 (d, <em>J</em> = 8.7 Hz, 2H), 1.00 (s, 9H), 0.24 (s, 6H). <sup>13</sup>C-NMR (126 MHz, CDCl<sub>3</sub>) δ 157.1; 155.8; 147.8; 147.3; 141.9; 141.5; 137.3; 131.3; 131.1; 130.1; 128.5; 128.4; 120.0; 119.5; 25.8; 18.4; −4.2. HRMS (ESI-TOF) [M + H]<sup>+</sup>
<em>m</em>/<em>z</em>: Calcd. for C<sub>22</sub>H<sub>22</sub>Cl<sub>4</sub>IN<sub>2</sub>OSi 624.9275, found: 624.9295.</p></section></section><section id="sec3dot1dot4-molecules-25-02213"><h4 class="pmc_sec_title">3.1.4. 3,3′,5,5′-Tetrachloro-2-iodo-2′-(4-hydroxyphenyl)-4,4′-bipyridine (<strong>9</strong>)</h4>
<p>To a stirred solution of bipyridine <strong>14</strong> (70 mg, 0.11 mmol) in THF (3 mL), under argon and at 0 °C, a TBAF solution (0.016 mL, 1M in THF) was slowly added. After 30 min stirring at 0 °C, the reaction was quenched with NH<sub>4</sub>Cl and extracted with dichloromethane (3 × 10 mL). After drying over Na<sub>2</sub>SO<sub>4</sub>, filtration, and concentration, the product was purified by chromatography on silica gel (cyclohexane/ethyl acetate 85/15) to give <strong>9</strong> as a viscous wax (50 mg, 87%). <sup>1</sup>H-NMR (500 MHz, CDCl<sub>3</sub>) δ 8.72 (s, 1H), 8.48 (s, 1H), 7.69 (d, <em>J</em> = 8.7 Hz, 2H), 6.93 (d, <em>J</em> = 8.7 Hz, 2H), 5.24 (s, 1H). <sup>13</sup>C- NMR (126 MHz, CDCl<sub>3</sub>) δ 156.9; 155.6; 147.8; 147.3; 142.0; 141.4; 137.3; 131.4; 131.2; 129.6; 128.6; 128.4; 119.5; 115.3. HRMS (ESI-TOF) [M + H]<sup>+</sup>
<em>m</em>/<em>z</em>: Calcd. for C<sub>22</sub>H<sub>22</sub>Cl<sub>4</sub>IN<sub>2</sub>OSi 510.8430, found: 510.8449.</p></section><section id="sec3dot1dot5-molecules-25-02213"><h4 class="pmc_sec_title">3.1.5. Synthesis of 3,3<strong>’</strong>,5,5<strong>’</strong>-Tetrachloro-2-iodo-2<strong>’</strong>-hydroxymethyl-4,4<strong>’</strong>-bipyridine (<strong>10</strong>)</h4>
<p>Bipyridine <strong>3</strong> (0.458 mmol, 250 mg) was dissolved in toluene (5 mL) and the solution was cooled to −78 °C. <em>n</em>-BuLi (1.2 M, 0.458 mmol, 0.38 mL) was added dropwise and the mixture was stirred at −78 °C for 1 h. DMF (0.916 mmol, 71 μL) was added and stirring was continued at the same temperature for 1 h. NaBH<sub>4</sub> (1.374 mmol, 52.2 mg) was added followed by methanol (0.5 mL), the cooling bath was removed and stirring was maintained for 1 h. The mixture was hydrolysed at 0 °C and extracted with ethyl acetate. After drying over Na<sub>2</sub>SO<sub>4</sub>, filtration and evaporation, the residue was purified twice by chromatography on silica gel (cyclohexane/ethyl acetate 9/1) to give bipyridine <strong>10</strong> as colourless wax (66 mg, 18%). <sup>1</sup>H-NMR (500 MHz, CDCl<sub>3</sub>) δ 8.67 (s, 1H); 8.48 (s, 1H); 4.85 (s, 2H), 3.98 (bs, 1H). <sup>13</sup>C-NMR (126 MHz, CDCl<sub>3</sub>) δ 155.3; 147.8; 146.2; 141.3; 140.3; 137.3; 131.1; 129.6; 128.0; 119.5; 61.9. HRMS (ESI-TOF) [M + H]<sup>+</sup>
<em>m</em>/<em>z</em>: Calcd. for C<sub>11</sub>H<sub>5</sub>Cl<sub>4</sub>IN<sub>2</sub>O 448.8273, found: 448.8281.</p></section><section id="sec3dot1dot6-molecules-25-02213"><h4 class="pmc_sec_title">3.1.6. Multimilligram Enantioseparation of <strong>7</strong>–<strong>10</strong>
</h4>
<p>An Agilent Technologies (Waldbronn, Germany) 1100 Series HPLC system (high-pressure binary gradient system equipped with a diode-array detector operating at multiple wavelengths (220, 254, 280, 360 nm), a programmable autosampler with a 20 L loop, and a thermostatted column compartment) was employed for analytical and multimilligram separations. Data acquisition and analysis were carried out with Agilent Technologies ChemStation Version B.04.03 chromatographic data software. The UV absorbance is reported as milliabsorbance units (mAU). Chiralcel OD-H (cellulose tris-3,5-dimethylphenylcarbamate), and Chiralpak IA (amylose tris-3,5-dimethyl- phenylcarbamate) (5 μm; Chiral Technologies Europe, Illkirch, France) were used as analytical (250 × 4.6 mm) chiral columns. HPLC-grade <em>n</em>-hexane, 2-propanol, and methanol were purchased and used as received. Analyses were performed in isocratic mode. Chromatographic separations were performed at 22 °C. After multimilligram enantioseparation, the collected fractions were analyzed under the same conditions used for separation to determine their enantiomeric excess (ee).</p></section></section><section id="sec3dot2-molecules-25-02213"><h3 class="pmc_sec_title">3.2. Biological Details</h3>
<section id="sec3dot2dot1-molecules-25-02213"><h4 class="pmc_sec_title">3.2.1. TTR Expression and Purification</h4>
<p>Recombinant WT-hTTR and mutants Y78F-, V30M-hTTR were produced using a pET expression system (GeneCust, Boynes, France) as essentially described by Dolado and co-workers [<a href="#B77-molecules-25-02213" class="usa-link" aria-describedby="B77-molecules-25-02213">77</a>]. All the hTTR proteins were expressed in <em>Escherichia coli</em> BL21-(DE3) cells harboring the corresponding plasmid. Expression cultures were grown in LB medium supplemented with 100 μg/mL Ampicillin at 36 °C to an optical density (at 600 nm) of 0.5. Protein expression was induced by addition of 0.4 mM IPTG for 5 h, then bacteria were harvested by centrifugation (5500 <em>g</em> for 20 min), washed with PBS and stored at −80 °C. Bacterial pellet was resuspended in 20 mM Tris-HCl pH 7.5, 1 mM ethylenediaminetetraacetic acid (EDTA), 100 μM PMSF. After enzymatic lysis with 1 mg/mL lysozyme, cells were treated with 2.5 μg/mL deoxyribonuclease I, 10 mM MgCl<sub>2</sub>, 50 mM NaCl, centrifuged and the clear supernatant collected. Proteins were fractionated by ammonium sulfate precipitation between 55 and 85% saturation. The precipitate was dissolved in 20 mM Tris-HCl pH 7.2, dialyzed against the same buffer and then fractionated by anion exchange chromatography on a Q-Sepharose column with a 0–0.6 M NaCl gradient in 20 mM Tris pH 7.2. A final step on Superdex 75 was conducted in 10 mM potassium phosphate pH 7.6 containing 100 mM KCl. The purity of protein fractions was assessed by standard SDS-PAGE analysis. Pure proteins equilibrated in buffer phosphate 10 mM pH 7.6, 100 mM KCl, 1 mM EDTA were stored at −20 °C. The extinction coefficients of WT- and V30M-TTR, 7.76 × 104 M<sup>−1</sup>cm<sup>−1</sup> [<a href="#B79-molecules-25-02213" class="usa-link" aria-describedby="B79-molecules-25-02213">79</a>], and Y78F-TTR, 6.958 × 104 M<sup>−1</sup>cm<sup>−1</sup> [<a href="#B42-molecules-25-02213" class="usa-link" aria-describedby="B42-molecules-25-02213">42</a>], were used to determine the protein concentration by measuring the absorbance at 280 nm.</p></section><section id="sec3dot2dot2-molecules-25-02213"><h4 class="pmc_sec_title">3.2.2. Acid-mediated TTR Fibril Formation Assay</h4>
<p>The assay was conducted as described by Klabunde and co-workers [<a href="#B34-molecules-25-02213" class="usa-link" aria-describedby="B34-molecules-25-02213">34</a>]. 150 μL of a 0.4 mg/mL (7.2 μM) stock of WT or mutants hTTR in 10 mM phosphate buffer pH 7.6, containing 100 mM KCl and 1 mM EDTA, were incubated with 1.45 μL of the selected drug (dissolved in DMSO) in an Eppendorf tube at 36 °C. After 30 min, the pH was lowered (up to 4.4 in the case of WT or 5.0 in the case of mutants) by adding 150 μL of acidic sodium acetate buffer 200 mM (pH 4.2 for WT, 4.8 for Y78F and V30M), containing 100 mM KCl and 1 mM EDTA. The mixtures were incubated at 36 °C for 72 h, after which the samples were vortexed and turbidity was measured at 400 nm in quartz cuvette. The final concentration of the protein was 3.6 μM, while drug concentrations was 3.6 or 7.2 μM. Data were expressed as percentage of fibril formation compared to that recorded in absence of drugs defined to be 100%. The percentage of fibril formation was determined by observing turbidity increase at 400 nm. Each measurement was run in triplicate. Both (<em>M</em>)-<strong>9</strong> and (<em>P</em>)-<strong>9</strong> were also tested at different concentrations ranging from 0 to 15 μM. The assay was conducted as described above using WT-TTR 3.6 μM.</p></section></section><section id="sec3dot3-molecules-25-02213"><h3 class="pmc_sec_title">3.3. Computationals</h3>
<section id="sec3dot3dot1-molecules-25-02213"><h4 class="pmc_sec_title">3.3.1. Electrostatic Potential Isosurfaces</h4>
<p>Conformational search was performed employing the density functional theory (DFT) method with the B3LYP functional and the 6-311G* basis set, and the Spartan’ 10 Version 1.1.0 (Wavefunction Inc., Irvine, CA, USA) program [<a href="#B80-molecules-25-02213" class="usa-link" aria-describedby="B80-molecules-25-02213">80</a>]. Geometry optimization and computation of electrostatic potentials isosurfaces and related parameters (<em>V</em><sub>S</sub> extrema, <em>V</em><sub>S,max</sub> and <em>V</em><sub>S,min</sub> values, given in kJ/mol) were performed by using Gaussian 09 (DFT, B3LYP, 6-311G*) (Wallingford, CT, USA) [<a href="#B81-molecules-25-02213" class="usa-link" aria-describedby="B81-molecules-25-02213">81</a>]. Search for the exact location of such EP maxima and minima was made through the Multiwfn code [<a href="#B82-molecules-25-02213" class="usa-link" aria-describedby="B82-molecules-25-02213">82</a>] and through its module enabling quantitative analyses of molecular surfaces (isovalue 0.002) [<a href="#B83-molecules-25-02213" class="usa-link" aria-describedby="B83-molecules-25-02213">83</a>].</p></section><section id="sec3dot3dot2-molecules-25-02213"><h4 class="pmc_sec_title">3.3.2. In Silico Docking Study</h4>
<p>The crystal structure complex TTR (chains ABCD)-T<sub>4</sub> was released from the RCSB protein databank (PDB ID: 1ICT) (<a href="http://www.rcsb.org" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">www.rcsb.org</a>) [<a href="#B2-molecules-25-02213" class="usa-link" aria-describedby="B2-molecules-25-02213">2</a>]. The crystallographic T<sub>4</sub> ligands were extracted and hydrogen atoms were added to the TTR structure using ADT module. Computational modelling experiments were carried out on a HP8100 PC and an EXXACT Tensor Workstation TWS-1686525-AMB with OS Ubuntu 18.4 or Windows 10, and Centos, respectively. The atomic charges were assigned using the Gasteiger-Marsili method for the 4,4′-bipyridines and the protein [<a href="#B84-molecules-25-02213" class="usa-link" aria-describedby="B84-molecules-25-02213">84</a>]. Binding of the compounds was analysed using MGLTools 1.5.7rc1 [<a href="#B85-molecules-25-02213" class="usa-link" aria-describedby="B85-molecules-25-02213">85</a>] and AutoDock 4.2.6 docking programs [<a href="#B68-molecules-25-02213" class="usa-link" aria-describedby="B68-molecules-25-02213">68</a>,<a href="#B69-molecules-25-02213" class="usa-link" aria-describedby="B69-molecules-25-02213">69</a>]. The structures were docked using the Lamarckian genetic algorithm (LGA). In the case of the blind docking procedure, the LGA was defined through a centred grid, coordinates: x = −7.5, y = −45.5, z = 38.5, with 126 × 126 × 126 grid points in x, y, z dimensions, respectively, spacing 0.550 Å. For the docking focused on the T<sub>4</sub> binding site, 40 × 40 × 40 grid points in x, y, z dimensions, respectively, spacing 0.375 Å. All 4,4′-bipyridine enantiomers were docked with the pyridyl-pyridyl bond fixed, blocking rotation. The Lamarckian genetic algorithm (LGA) of up to 100 runs was set to the population size of 150 individuals, maximum number of generations and energy evaluations of 27,000 and 25,000,000, respectively. From the estimated free energy of ligand binding (E.F.E.B., ΔG), the estimated inhibition constant (E.I.C., K<sub>i</sub>) for each 4,4′-bipyridine was calculated. K<sub>i</sub> is calculated by the equation: K<sub>i</sub> = exp [(ΔG × 1000)/(R × T)] where ΔG is the docking estimated free energy, R (gas constant) = 1.98719 cal/(K × mol) and T = 298.15 K. Graphical representation of the poses derived from the docking calculation was obtained using the software Chimera 1.13.1 [<a href="#B70-molecules-25-02213" class="usa-link" aria-describedby="B70-molecules-25-02213">70</a>]. 4,4′-Bipyridines <strong>1</strong>–<strong>10</strong> were constructed by using the standard bond lengths and angles from the fragment database of GaussView 5.0 and optimized with Gaussian 09 (DFT, B3LYP, 6-311G*) [<a href="#B81-molecules-25-02213" class="usa-link" aria-describedby="B81-molecules-25-02213">81</a>,<a href="#B86-molecules-25-02213" class="usa-link" aria-describedby="B86-molecules-25-02213">86</a>]. The explicit σ-hole (ESH) was used as previously described [<a href="#B51-molecules-25-02213" class="usa-link" aria-describedby="B51-molecules-25-02213">51</a>,<a href="#B64-molecules-25-02213" class="usa-link" aria-describedby="B64-molecules-25-02213">64</a>,<a href="#B65-molecules-25-02213" class="usa-link" aria-describedby="B65-molecules-25-02213">65</a>], in order to account for the charge anisotropy of the electrostatic potential on top of the halogen atoms. On this basis, a massless dummy atom connected to <em>I</em> and <em>Cl</em> was introduced manually, by using distance and charge values as described by Hobza and co-workers [<a href="#B65-molecules-25-02213" class="usa-link" aria-describedby="B65-molecules-25-02213">65</a>]. The parameters used for <em>Cl</em> and <em>I</em> were 1.0, 1.6 Å, and 0.1, 0.3 units of positive charge for the extra point (ExP), respectively (<a href="#app1-molecules-25-02213" class="usa-link">Supplementary Information, Table S7</a>). The reliability of the docking approach was further verified by extracting the T<sub>4</sub> ligands from the T<sub>4</sub> binding pocket of the 1ICT.pdb, 3.00 Å resolution crystal structure, and by considering it as a normal ligand. A massless dummy atom connected to the iodines of T<sub>4</sub> was introduced manually in order to model the σ-hole, as previously described. After repositioning of T<sub>4</sub> into the protein, the new T<sub>4</sub> location was in accord to the original X-ray structure of TTR (<a href="#app1-molecules-25-02213" class="usa-link">Supplementary Information, Figure S3</a>), with only minimal conformational changes (RMSD 0.57 Å), therefore confirming the reliability of the system.</p></section></section></section><section id="sec4-molecules-25-02213"><h2 class="pmc_sec_title">4. Conclusions</h2>
<p>Unexplored as a substructure for the development of TTR stabilizers, the 4,4′-bipyridyl motif has been proposed and used herein for the development of new potential fibrillogenesis inhibitors. Among the screened derivatives, the 3,3′,5,5′-tetrachloro-2-iodo-4,4′-bipyridyl core emerged as a key chiral scaffold, and several derivatives containing a 2′-substituent were thus prepared by focused/specific synthetic procedures. The enantioseparation of these chiral compounds made available their enantiomers, which were tested against acid-mediated TTR fibrillogenesis. For each compound, low or moderate differences were observed between the enantiomer pairs <em>M</em>/<em>P</em>. Among all enantiomers, (<em>M</em>)-3,3′,5,5′-tetrachloro-2′-(4-hydroxyphenyl)- 2-iodo-4,4′-bipyridine proved to be able to significantly reduce FF of WT-TTR (16% at 7.2 μM of inhibitor concentration). In silico docking studies within the T<sub>4</sub> pocket were carried out in order to rationalize the binding mode and hypothesize a possible molecular mechanism for the observed inhibition activity. Both experimental and theoretical results evidenced the importance of HB sites located in the distinctive 2′-substituent and the capability of 2-iodine as XB donor. Despite the fact that some issues such as plasma TTR binding selectivity has still to be tackled and that the new structures need optimization, the present study revealed the potentiality of halogenated 4,4′-bipyridines for the development of new TTR amyloidogenesis inhibitors.</p></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p>This work has been supported by Università Ca’ Foscari Venezia, Italy (Dipartimento di Scienze Molecolari e Nanosistemi, DSMN ADIR funds). We thank the International Center Frontier Research in Chemistry (icFRC) and the Laboratory of Excellence for Complex System Chemistry (LabEx CSC). M.A., PhD program at the DISTABIF, Università degli Studi della Campania “Luigi Vanvitelli”, PhD fellowship POR Campania FSE 2014/2020 “Dottorati di Ricerca Con Caratterizzazione Industriale”.</p></section><section id="app1-molecules-25-02213" class="app"><h2 class="pmc_sec_title">Supplementary Materials</h2>
<p>The following are available online: Figure S1: <em>V</em><sub>S</sub> molecular isosurfaces (0.002 au) calculated for (<em>P</em>) and (<em>M</em>) enantiomers of <strong>9</strong>, T<sub>4</sub>, and Tafamidis, Figure S2: Blind docking poses of compounds (<em>M</em>)-<strong>3</strong> and <strong>6</strong> on the whole TTR, Figure S3: Comparison of the docked pose of T<sub>4</sub> into TTR (BD:T<sub>4</sub> binding pocket) with the crystallographic structure of T<sub>4</sub> (released from PDB ID: 1ICT), Figure S4: Linear regression analysis describing the relationships between FF% and calculated EFEB by docking in the T<sub>4</sub> pocket (BD), Figures S5-S16: NMR spectra, Figures S17-S20: HPLC chromatograms, Figures S21-S24: ECD spectra, Figures S25-S28: comparison of calculated and experimental ECD spectra, Figure S29: Inhibition of WT-TTR in the presence of (<em>M</em>)-<strong>9</strong> and (<em>P</em>)-<strong>9</strong> tested at different concentrations, Table S1: Calculated <em>V</em><sub>S</sub> on a 0.002 au isosurface and molecular geometrical parameters for polyhalogenated 4,4′-bipyridines <strong>1</strong>–<strong>6</strong>, Table S2: Calculated <em>V</em><sub>S</sub> on a 0.002 au isosurface and molecular geometrical parameters for Tafamidis and Thyroxyne (T<sub>4</sub>) (from crystal structure, PDB ID:1ICT), Table S3: Calculated distribution, pattern and properties of conformations A and B of 4,4′-bipyridines <strong>7</strong>–<strong>9</strong>, Table S4: Calculated distribution, pattern and properties of conformations A-F of 4,4′-bipyridine <strong>10</strong>, Table S5: Calculated <em>V</em><sub>S</sub> on a 0.002 au isosurface and molecular geometrical parameters for conformations A and B of 2′-aryl-3,3′,5,5′-tetrachloro-2-iodo-4,4′-bipyridines <strong>7</strong>–<strong>9</strong>, Table S6: Calculated <em>V</em><sub>S</sub> on a 0.002 au isosurface and molecular geometrical parameters for conformations A-F of 4,4′-bipyridine <strong>10</strong>, Table S7: Parameters used for the extra point (ExP) of charge (X = Cl, I), Table S8: Blind docking resultsa targeting poses found in the T<sub>4</sub> binding pockets, Table S9: Docking results for 4,4′-bipyridines <strong>1</strong>–<strong>6</strong> in the T<sub>4</sub> binding pocket, Table S10: Optimized multimilligram enantioseparation of 4,4′-bipyridines <strong>7</strong>–<strong>10</strong>.</p>
<section class="sm xbox font-sm" id="molecules-25-02213-s001"><div class="media p"><div class="caption">
<a href="/articles/instance/7248964/bin/molecules-25-02213-s001.pdf" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (2.4MB, pdf) </sup>
</div></div></section></section><section id="notes1"><h2 class="pmc_sec_title">Author Contributions</h2>
<p>Conceptualization, P.P. (Paola Peluso) and V.M.; methodology, P.P. (Paola Peluso), A.D. and G.A.; syntheses, V.M., P.P. (Patrick Pale) and R.W.; HPLC, P.P. (Paola Peluso); X-ray analysis and TD-DFT calculations, E.A.; <em>V</em><sub>s</sub> calculations and docking, P.P. (Paola Peluso), A.D. and R.D.; biological experiments, G.A. and M.A.; data curation, P.P. (Paola Peluso); writing-original draft preparation, P.P (Paola Peluso) and V.M.; writing, review and editing, all authors; funding acquisition, V.M. and S.C. All authors have read and agreed to the published version of the manuscript.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>This research was funded by the International Center Frontier Research in Chemistry (icFRC), the LabEx CSC (ANR-10-LABX-0026 CSC) and Venice Ca’ Foscari University, Italy (Department of Molecular Science and Nanosystems, DSMN ADIR funds).</p></section><section id="notes3"><h2 class="pmc_sec_title">Conflicts of Interest</h2>
<p>The authors declare no conflict of interest.</p></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn1"><p><strong>Sample Availability:</strong> Samples of the compounds <strong>1</strong>–<strong>10</strong> are available from the authors.</p></div></div></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="B1-molecules-25-02213">
<span class="label">1.</span><cite>Wojtczak A., Cody V., Luft J.R., Pangborn W. Structures of human transthyretin complexed with thyroxine at 2.0 Å resolution and 3′,5′-dinitro-N-acetyl-L-thyronine at 2.2 Å resolution. Acta Cryst. 1996;52:758–765. doi: 10.1107/S0907444996003046.</cite> [<a href="https://doi.org/10.1107/S0907444996003046" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15299640/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acta%20Cryst.&amp;title=Structures%20of%20human%20transthyretin%20complexed%20with%20thyroxine%20at%202.0%20%C3%85%20resolution%20and%203%E2%80%B2,5%E2%80%B2-dinitro-N-acetyl-L-thyronine%20at%202.2%20%C3%85%20resolution&amp;author=A.%20Wojtczak&amp;author=V.%20Cody&amp;author=J.R.%20Luft&amp;author=W.%20Pangborn&amp;volume=52&amp;publication_year=1996&amp;pages=758-765&amp;pmid=15299640&amp;doi=10.1107/S0907444996003046&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B2-molecules-25-02213">
<span class="label">2.</span><cite>Wojtczak A., Neumann P., Cody V. Structure of a new polymorphic monoclinic form of human transthyretin at 3 Å resolution reveals a mixed complex between unliganded and T4-bound tetramers of TTR. Acta Cryst. 2001;57:957–967. doi: 10.1107/S0907444901006047.</cite> [<a href="https://doi.org/10.1107/S0907444901006047" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11418763/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acta%20Cryst.&amp;title=Structure%20of%20a%20new%20polymorphic%20monoclinic%20form%20of%20human%20transthyretin%20at%203%20%C3%85%20resolution%20reveals%20a%20mixed%20complex%20between%20unliganded%20and%20T4-bound%20tetramers%20of%20TTR&amp;author=A.%20Wojtczak&amp;author=P.%20Neumann&amp;author=V.%20Cody&amp;volume=57&amp;publication_year=2001&amp;pages=957-967&amp;pmid=11418763&amp;doi=10.1107/S0907444901006047&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B3-molecules-25-02213">
<span class="label">3.</span><cite>Palaninathan S.K. Nearly 200 X-Ray crystal structures of transthyretin: What do they tell us about this protein and the design of drugs for TTR amyloidosis? Curr. Med. Chem. 2012;19:2324–2342. doi: 10.2174/092986712800269335.</cite> [<a href="https://doi.org/10.2174/092986712800269335" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22471981/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr.%20Med.%20Chem.&amp;title=Nearly%20200%20X-Ray%20crystal%20structures%20of%20transthyretin:%20What%20do%20they%20tell%20us%20about%20this%20protein%20and%20the%20design%20of%20drugs%20for%20TTR%20amyloidosis?&amp;author=S.K.%20Palaninathan&amp;volume=19&amp;publication_year=2012&amp;pages=2324-2342&amp;pmid=22471981&amp;doi=10.2174/092986712800269335&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B4-molecules-25-02213">
<span class="label">4.</span><cite>Blaney J.M., Jorgensen E.C., Connolly M.L., Ferrin T.E., Langridge R., Oatley S.J., Burridge J.M., Blake C.C.F. Computer graphics in drug design: Molecular modelling of thyroid hormone-prealbumin interactions. J. Med. Chem. 1982;25:785–790. doi: 10.1021/jm00349a004.</cite> [<a href="https://doi.org/10.1021/jm00349a004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7108895/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Med.%20Chem.&amp;title=Computer%20graphics%20in%20drug%20design:%20Molecular%20modelling%20of%20thyroid%20hormone-prealbumin%20interactions&amp;author=J.M.%20Blaney&amp;author=E.C.%20Jorgensen&amp;author=M.L.%20Connolly&amp;author=T.E.%20Ferrin&amp;author=R.%20Langridge&amp;volume=25&amp;publication_year=1982&amp;pages=785-790&amp;pmid=7108895&amp;doi=10.1021/jm00349a004&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B5-molecules-25-02213">
<span class="label">5.</span><cite>Khanam H., Ali A., Asif M. Shamsuzzaman Neurodegenerative diseases linked to misfolded proteins and their therapeutic approaches: A review. Eur. J. Med. Chem. 2016;124:1121–1141. doi: 10.1016/j.ejmech.2016.08.006.</cite> [<a href="https://doi.org/10.1016/j.ejmech.2016.08.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27597727/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20J.%20Med.%20Chem.&amp;title=Shamsuzzaman%20Neurodegenerative%20diseases%20linked%20to%20misfolded%20proteins%20and%20their%20therapeutic%20approaches:%20A%20review&amp;author=H.%20Khanam&amp;author=A.%20Ali&amp;author=M.%20Asif&amp;volume=124&amp;publication_year=2016&amp;pages=1121-1141&amp;pmid=27597727&amp;doi=10.1016/j.ejmech.2016.08.006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B6-molecules-25-02213">
<span class="label">6.</span><cite>Pande M., Srivastava R. Molecular and clinical insights into protein misfolding and associated amyloidosis. Eur. J. Med. Chem. 2019;184:111753. doi: 10.1016/j.ejmech.2019.111753.</cite> [<a href="https://doi.org/10.1016/j.ejmech.2019.111753" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31622853/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20J.%20Med.%20Chem.&amp;title=Molecular%20and%20clinical%20insights%20into%20protein%20misfolding%20and%20associated%20amyloidosis&amp;author=M.%20Pande&amp;author=R.%20Srivastava&amp;volume=184&amp;publication_year=2019&amp;pages=111753&amp;pmid=31622853&amp;doi=10.1016/j.ejmech.2019.111753&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B7-molecules-25-02213">
<span class="label">7.</span><cite>McCutchen S.L., Lai Z., Miroy G.J., Kelly J.W., Colón W. Comparison of lethal and nonlethal transthyretin variants and their relationship to amyloid disease. Biochemistry. 1995;34:13527–13536. doi: 10.1021/bi00041a032.</cite> [<a href="https://doi.org/10.1021/bi00041a032" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7577941/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochemistry&amp;title=Comparison%20of%20lethal%20and%20nonlethal%20transthyretin%20variants%20and%20their%20relationship%20to%20amyloid%20disease&amp;author=S.L.%20McCutchen&amp;author=Z.%20Lai&amp;author=G.J.%20Miroy&amp;author=J.W.%20Kelly&amp;author=W.%20Col%C3%B3n&amp;volume=34&amp;publication_year=1995&amp;pages=13527-13536&amp;pmid=7577941&amp;doi=10.1021/bi00041a032&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B8-molecules-25-02213">
<span class="label">8.</span><cite>Redondo C., Damas A.M., Olofsson A., Lundgren E., Saraiva M.J.M. Search for intermediate structures in transthyretin fibrillogenesis: Soluble tetrameric TYR78Phe TTR expresses a specific epitope present only in amyloid fibrils. J. Mol. Biol. 2000;304:461–470. doi: 10.1006/jmbi.2000.4220.</cite> [<a href="https://doi.org/10.1006/jmbi.2000.4220" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11090287/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Mol.%20Biol.&amp;title=Search%20for%20intermediate%20structures%20in%20transthyretin%20fibrillogenesis:%20Soluble%20tetrameric%20TYR78Phe%20TTR%20expresses%20a%20specific%20epitope%20present%20only%20in%20amyloid%20fibrils&amp;author=C.%20Redondo&amp;author=A.M.%20Damas&amp;author=A.%20Olofsson&amp;author=E.%20Lundgren&amp;author=M.J.M.%20Saraiva&amp;volume=304&amp;publication_year=2000&amp;pages=461-470&amp;pmid=11090287&amp;doi=10.1006/jmbi.2000.4220&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B9-molecules-25-02213">
<span class="label">9.</span><cite>Gimeno A., Santos L.M., Alemi M., Rivas J., Blasi D., Cotrina E.Y., Llop J., Valencia G., Cardoso I., Quintana J., et al.  Insights on the interaction between transthyretin and Aβ in solution. A saturation transfer difference (STD) NMR analysis of the role of iododiflunisal. J. Med. Chem. 2017;60:5749–5758. doi: 10.1021/acs.jmedchem.7b00428.</cite> [<a href="https://doi.org/10.1021/acs.jmedchem.7b00428" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28587455/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Med.%20Chem.&amp;title=Insights%20on%20the%20interaction%20between%20transthyretin%20and%20A%CE%B2%20in%20solution.%20A%20saturation%20transfer%20difference%20(STD)%20NMR%20analysis%20of%20the%20role%20of%20iododiflunisal&amp;author=A.%20Gimeno&amp;author=L.M.%20Santos&amp;author=M.%20Alemi&amp;author=J.%20Rivas&amp;author=D.%20Blasi&amp;volume=60&amp;publication_year=2017&amp;pages=5749-5758&amp;pmid=28587455&amp;doi=10.1021/acs.jmedchem.7b00428&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B10-molecules-25-02213">
<span class="label">10.</span><cite>Rios X., Gómez-Vallejo V., Martín A., Cossío U., Morcillo M.A., Alemi M., Cardoso I., Quintana J., Jimeénez-Barbero J., Cotrina E.Y., et al.  Radiochemical examination of transthyretin (TTR) brain penetration assisted by iododiflunisal, a TTR tetramer stabilizer and a new candidate drug for AD. Sci. Rep. 2019;9:13672. doi: 10.1038/s41598-019-50071-w.</cite> [<a href="https://doi.org/10.1038/s41598-019-50071-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6754432/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31541162/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci.%20Rep.&amp;title=Radiochemical%20examination%20of%20transthyretin%20(TTR)%20brain%20penetration%20assisted%20by%20iododiflunisal,%20a%20TTR%20tetramer%20stabilizer%20and%20a%20new%20candidate%20drug%20for%20AD&amp;author=X.%20Rios&amp;author=V.%20G%C3%B3mez-Vallejo&amp;author=A.%20Mart%C3%ADn&amp;author=U.%20Coss%C3%ADo&amp;author=M.A.%20Morcillo&amp;volume=9&amp;publication_year=2019&amp;pages=13672&amp;pmid=31541162&amp;doi=10.1038/s41598-019-50071-w&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B11-molecules-25-02213">
<span class="label">11.</span><cite>Miroy G.J., Lai Z., Lashuel H.A., Peterson S.A., Strang C., Kelly J.W. Inhibiting transthyretin amyloid fibril formation via protein stabilization. Proc. Natl. Acad. Sci. USA. 1996;93:15051–15056. doi: 10.1073/pnas.93.26.15051.</cite> [<a href="https://doi.org/10.1073/pnas.93.26.15051" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC26354/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8986762/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proc.%20Natl.%20Acad.%20Sci.%20USA&amp;title=Inhibiting%20transthyretin%20amyloid%20fibril%20formation%20via%20protein%20stabilization&amp;author=G.J.%20Miroy&amp;author=Z.%20Lai&amp;author=H.A.%20Lashuel&amp;author=S.A.%20Peterson&amp;author=C.%20Strang&amp;volume=93&amp;publication_year=1996&amp;pages=15051-15056&amp;pmid=8986762&amp;doi=10.1073/pnas.93.26.15051&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B12-molecules-25-02213">
<span class="label">12.</span><cite>Hammarström P., Wiseman R.L., Powers E.T., Kelly J.W. Prevention of transthyretin amyloid disease by changing protein misfolding energetics. Science. 2003;299:713–716. doi: 10.1126/science.1079589.</cite> [<a href="https://doi.org/10.1126/science.1079589" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12560553/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Prevention%20of%20transthyretin%20amyloid%20disease%20by%20changing%20protein%20misfolding%20energetics&amp;author=P.%20Hammarstr%C3%B6m&amp;author=R.L.%20Wiseman&amp;author=E.T.%20Powers&amp;author=J.W.%20Kelly&amp;volume=299&amp;publication_year=2003&amp;pages=713-716&amp;pmid=12560553&amp;doi=10.1126/science.1079589&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B13-molecules-25-02213">
<span class="label">13.</span><cite>Yee A.W., Aldeghi M., Blakeley M.P., Ostermann A., Mas P.J., Moulin M., de Sanctis D., Bowler M.W., Mueller-Dieckmann C., Mitchell E.P., et al.  A molecular mechanism for transthyretin amyloidogenesis. Nat. Commun. 2019;10:925. doi: 10.1038/s41467-019-08609-z.</cite> [<a href="https://doi.org/10.1038/s41467-019-08609-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6390107/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30804345/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Commun.&amp;title=A%20molecular%20mechanism%20for%20transthyretin%20amyloidogenesis&amp;author=A.W.%20Yee&amp;author=M.%20Aldeghi&amp;author=M.P.%20Blakeley&amp;author=A.%20Ostermann&amp;author=P.J.%20Mas&amp;volume=10&amp;publication_year=2019&amp;pages=925&amp;pmid=30804345&amp;doi=10.1038/s41467-019-08609-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B14-molecules-25-02213">
<span class="label">14.</span><cite>Rosenblum H., Castano A., Alvarez J., Goldsmith J., Helmke S., Maurer M.S. TTR (Transthyretin) stabilizers are associated with improved survival in patients with TTR cardiac amyloidosis. Circ. Heart Fail. 2018;11:e004769. doi: 10.1161/CIRCHEARTFAILURE.117.004769.</cite> [<a href="https://doi.org/10.1161/CIRCHEARTFAILURE.117.004769" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5886729/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29615436/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circ.%20Heart%20Fail.&amp;title=TTR%20(Transthyretin)%20stabilizers%20are%20associated%20with%20improved%20survival%20in%20patients%20with%20TTR%20cardiac%20amyloidosis&amp;author=H.%20Rosenblum&amp;author=A.%20Castano&amp;author=J.%20Alvarez&amp;author=J.%20Goldsmith&amp;author=S.%20Helmke&amp;volume=11&amp;publication_year=2018&amp;pages=e004769&amp;pmid=29615436&amp;doi=10.1161/CIRCHEARTFAILURE.117.004769&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B15-molecules-25-02213">
<span class="label">15.</span><cite>Oza V.B., Smith C., Raman P., Koepf E.K., Lashuel H.A., Petrassi H.M., Chiang K.P., Powers E.T., Sacchettini J.C., Kelly J.W. Synthesis, structure, and activity of diclofenac analogues as transthyretin amyloid fibril formation inhibitors. J. Med. Chem. 2002;45:321–332. doi: 10.1021/jm010257n.</cite> [<a href="https://doi.org/10.1021/jm010257n" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11784137/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Med.%20Chem.&amp;title=Synthesis,%20structure,%20and%20activity%20of%20diclofenac%20analogues%20as%20transthyretin%20amyloid%20fibril%20formation%20inhibitors&amp;author=V.B.%20Oza&amp;author=C.%20Smith&amp;author=P.%20Raman&amp;author=E.K.%20Koepf&amp;author=H.A.%20Lashuel&amp;volume=45&amp;publication_year=2002&amp;pages=321-332&amp;pmid=11784137&amp;doi=10.1021/jm010257n&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B16-molecules-25-02213">
<span class="label">16.</span><cite>Adamski-Werner S.L., Palaninathan S.K., Sacchettini J.C., Kelly J.W. Diflunisal analogues stabilize the native state of transthyretin. Potent inhibition of amyloidogenesis. J. Med. Chem. 2004;47:355–374. doi: 10.1021/jm030347n.</cite> [<a href="https://doi.org/10.1021/jm030347n" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14711308/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Med.%20Chem.&amp;title=Diflunisal%20analogues%20stabilize%20the%20native%20state%20of%20transthyretin.%20Potent%20inhibition%20of%20amyloidogenesis&amp;author=S.L.%20Adamski-Werner&amp;author=S.K.%20Palaninathan&amp;author=J.C.%20Sacchettini&amp;author=J.W.%20Kelly&amp;volume=47&amp;publication_year=2004&amp;pages=355-374&amp;pmid=14711308&amp;doi=10.1021/jm030347n&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B17-molecules-25-02213">
<span class="label">17.</span><cite>Gales L., Macedo-Ribeiro S., Arsequell G., Valencia G., Saraiva M.J., Damas A.M. Human transthyretin in complex with iododiflunisal: Structural features associated with a potent amyloid inhibitor. Biochem. J. 2005;388:615–621. doi: 10.1042/BJ20042035.</cite> [<a href="https://doi.org/10.1042/BJ20042035" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1138969/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15689188/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochem.%20J.&amp;title=Human%20transthyretin%20in%20complex%20with%20iododiflunisal:%20Structural%20features%20associated%20with%20a%20potent%20amyloid%20inhibitor&amp;author=L.%20Gales&amp;author=S.%20Macedo-Ribeiro&amp;author=G.%20Arsequell&amp;author=G.%20Valencia&amp;author=M.J.%20Saraiva&amp;volume=388&amp;publication_year=2005&amp;pages=615-621&amp;pmid=15689188&amp;doi=10.1042/BJ20042035&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B18-molecules-25-02213">
<span class="label">18.</span><cite>Johnson S.M., Wiseman R.L., Sekijima Y., Green N.S., Adamski-Werner S.L., Kelly J.W. Native state kinetic stabilization as a strategy to ameliorate protein misfolding diseases: A focus on the transthyretin amyloidosis. Acc. Chem. Res. 2005;38:911–921. doi: 10.1021/ar020073i.</cite> [<a href="https://doi.org/10.1021/ar020073i" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16359163/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acc.%20Chem.%20Res.&amp;title=Native%20state%20kinetic%20stabilization%20as%20a%20strategy%20to%20ameliorate%20protein%20misfolding%20diseases:%20A%20focus%20on%20the%20transthyretin%20amyloidosis&amp;author=S.M.%20Johnson&amp;author=R.L.%20Wiseman&amp;author=Y.%20Sekijima&amp;author=N.S.%20Green&amp;author=S.L.%20Adamski-Werner&amp;volume=38&amp;publication_year=2005&amp;pages=911-921&amp;pmid=16359163&amp;doi=10.1021/ar020073i&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B19-molecules-25-02213">
<span class="label">19.</span><cite>Miyata M., Sato T., Kugimiya M., Sho M., Nakamura T., Ikemizu S., Chirifu M., Mizuguchi M., Nabeshima Y., Suwa Y., et al.  The crystal structure of the green tea polyphenol (-)-epigallocatechin gallate-transthyretin complex reveals a novel binding site distinct from the thyroxine binding site. Biochemistry. 2010;49:6104–6114. doi: 10.1021/bi1004409.</cite> [<a href="https://doi.org/10.1021/bi1004409" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20565072/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochemistry&amp;title=The%20crystal%20structure%20of%20the%20green%20tea%20polyphenol%20(-)-epigallocatechin%20gallate-transthyretin%20complex%20reveals%20a%20novel%20binding%20site%20distinct%20from%20the%20thyroxine%20binding%20site&amp;author=M.%20Miyata&amp;author=T.%20Sato&amp;author=M.%20Kugimiya&amp;author=M.%20Sho&amp;author=T.%20Nakamura&amp;volume=49&amp;publication_year=2010&amp;pages=6104-6114&amp;pmid=20565072&amp;doi=10.1021/bi1004409&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B20-molecules-25-02213">
<span class="label">20.</span><cite>Yokoyama T., Kosada Y., Mizuguchi M. Inhibitory activities of propolis and its promising component, caffeic acid phenethyl ester, against amyloidogenesis of human transthyretin. J. Med. Chem. 2014;57:8928–8935. doi: 10.1021/jm500997m.</cite> [<a href="https://doi.org/10.1021/jm500997m" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25314129/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Med.%20Chem.&amp;title=Inhibitory%20activities%20of%20propolis%20and%20its%20promising%20component,%20caffeic%20acid%20phenethyl%20ester,%20against%20amyloidogenesis%20of%20human%20transthyretin&amp;author=T.%20Yokoyama&amp;author=Y.%20Kosada&amp;author=M.%20Mizuguchi&amp;volume=57&amp;publication_year=2014&amp;pages=8928-8935&amp;pmid=25314129&amp;doi=10.1021/jm500997m&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B21-molecules-25-02213">
<span class="label">21.</span><cite>Ortore G., Orlandini E., Braca A., Ciccone L., Rossello A., Martinelli A., Nencetti S. Targeting different transthyretin binding sites with unusual natural compounds. ChemMedChem. 2016;11:1865–1874. doi: 10.1002/cmdc.201600092.</cite> [<a href="https://doi.org/10.1002/cmdc.201600092" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27159149/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ChemMedChem&amp;title=Targeting%20different%20transthyretin%20binding%20sites%20with%20unusual%20natural%20compounds&amp;author=G.%20Ortore&amp;author=E.%20Orlandini&amp;author=A.%20Braca&amp;author=L.%20Ciccone&amp;author=A.%20Rossello&amp;volume=11&amp;publication_year=2016&amp;pages=1865-1874&amp;pmid=27159149&amp;doi=10.1002/cmdc.201600092&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B22-molecules-25-02213">
<span class="label">22.</span><cite>Kim B., Park H., Lee S.K., Park S.J., Koo T.-S., Kang N.S., Hong K.B., Choi S. Systemic optimization and structural evaluation of quinoline derivatives as transthyretin amyloidogenesis inhibitors. Eur. J. Med. Chem. 2016;123:777–787. doi: 10.1016/j.ejmech.2016.08.003.</cite> [<a href="https://doi.org/10.1016/j.ejmech.2016.08.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27541261/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20J.%20Med.%20Chem.&amp;title=Systemic%20optimization%20and%20structural%20evaluation%20of%20quinoline%20derivatives%20as%20transthyretin%20amyloidogenesis%20inhibitors&amp;author=B.%20Kim&amp;author=H.%20Park&amp;author=S.K.%20Lee&amp;author=S.J.%20Park&amp;author=T.-S.%20Koo&amp;volume=123&amp;publication_year=2016&amp;pages=777-787&amp;pmid=27541261&amp;doi=10.1016/j.ejmech.2016.08.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B23-molecules-25-02213">
<span class="label">23.</span><cite>Smith T.P., Windsor I.W., Forest K.T., Raines R.T. Stilbene boronic acids form a covalent bond with human transthyretin and inhibit its aggregation. J. Med. Chem. 2017;60:7820–7834. doi: 10.1021/acs.jmedchem.7b00952.</cite> [<a href="https://doi.org/10.1021/acs.jmedchem.7b00952" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5659721/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28920684/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Med.%20Chem.&amp;title=Stilbene%20boronic%20acids%20form%20a%20covalent%20bond%20with%20human%20transthyretin%20and%20inhibit%20its%20aggregation&amp;author=T.P.%20Smith&amp;author=I.W.%20Windsor&amp;author=K.T.%20Forest&amp;author=R.T.%20Raines&amp;volume=60&amp;publication_year=2017&amp;pages=7820-7834&amp;pmid=28920684&amp;doi=10.1021/acs.jmedchem.7b00952&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B24-molecules-25-02213">
<span class="label">24.</span><cite>Yokoyama T., Mizuguchi M. Inhibition of the amyloidogenesis of transthyretin by natural products and synthetic compounds. Biol. Pharm. Bull. 2018;41:979–984. doi: 10.1248/bpb.b18-00166.</cite> [<a href="https://doi.org/10.1248/bpb.b18-00166" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29962408/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biol.%20Pharm.%20Bull.&amp;title=Inhibition%20of%20the%20amyloidogenesis%20of%20transthyretin%20by%20natural%20products%20and%20synthetic%20compounds&amp;author=T.%20Yokoyama&amp;author=M.%20Mizuguchi&amp;volume=41&amp;publication_year=2018&amp;pages=979-984&amp;pmid=29962408&amp;doi=10.1248/bpb.b18-00166&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B25-molecules-25-02213">
<span class="label">25.</span><cite>Yokoyama T., Mizuguchi M. Crown ethers as transthyretin amyloidogenesis inhibitors. J. Med. Chem. 2019;62:2076–2082. doi: 10.1021/acs.jmedchem.8b01700.</cite> [<a href="https://doi.org/10.1021/acs.jmedchem.8b01700" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30688456/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Med.%20Chem.&amp;title=Crown%20ethers%20as%20transthyretin%20amyloidogenesis%20inhibitors&amp;author=T.%20Yokoyama&amp;author=M.%20Mizuguchi&amp;volume=62&amp;publication_year=2019&amp;pages=2076-2082&amp;pmid=30688456&amp;doi=10.1021/acs.jmedchem.8b01700&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B26-molecules-25-02213">
<span class="label">26.</span><cite>Green N.S., Palaninathan S.K., Sacchettini J.C., Kelly J.W. Synthesis and characterization of potent bivalent amyloidosis inhibitors that bind prior to transthyretin tetramerization. J. Am. Chem. Soc. 2003;125:13404–13414. doi: 10.1021/ja030294z.</cite> [<a href="https://doi.org/10.1021/ja030294z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14583036/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Am.%20Chem.%20Soc.&amp;title=Synthesis%20and%20characterization%20of%20potent%20bivalent%20amyloidosis%20inhibitors%20that%20bind%20prior%20to%20transthyretin%20tetramerization&amp;author=N.S.%20Green&amp;author=S.K.%20Palaninathan&amp;author=J.C.%20Sacchettini&amp;author=J.W.%20Kelly&amp;volume=125&amp;publication_year=2003&amp;pages=13404-13414&amp;pmid=14583036&amp;doi=10.1021/ja030294z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B27-molecules-25-02213">
<span class="label">27.</span><cite>Corazza A., Verona G., Waudby C.A., Mangione P.P., Bingham R., Uings I., Canetti D., Nocerino P., Taylor G.W., Pepys M.B., et al.  Binding of monovalent and bivalent ligands by transthyretin causes different short- and long-distance conformational changes. J. Med. Chem. 2019;62:8274–8283. doi: 10.1021/acs.jmedchem.9b01037.</cite> [<a href="https://doi.org/10.1021/acs.jmedchem.9b01037" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6863598/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31393717/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Med.%20Chem.&amp;title=Binding%20of%20monovalent%20and%20bivalent%20ligands%20by%20transthyretin%20causes%20different%20short-%20and%20long-distance%20conformational%20changes&amp;author=A.%20Corazza&amp;author=G.%20Verona&amp;author=C.A.%20Waudby&amp;author=P.P.%20Mangione&amp;author=R.%20Bingham&amp;volume=62&amp;publication_year=2019&amp;pages=8274-8283&amp;pmid=31393717&amp;doi=10.1021/acs.jmedchem.9b01037&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B28-molecules-25-02213">
<span class="label">28.</span><cite>Inoue M., Ueda M., Higashi T., Anno T., Fujisawa K., Motoyama K., Mizuguchi M., Ando Y., Jono H., Arima H. Therapeutic potential of polyamidoamine dendrimer for amyloidogenic transthyretin amyloidosis. ACS Chem. Neurosci. 2019;10:2584–2590. doi: 10.1021/acschemneuro.9b00059.</cite> [<a href="https://doi.org/10.1021/acschemneuro.9b00059" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30912637/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACS%20Chem.%20Neurosci.&amp;title=Therapeutic%20potential%20of%20polyamidoamine%20dendrimer%20for%20amyloidogenic%20transthyretin%20amyloidosis&amp;author=M.%20Inoue&amp;author=M.%20Ueda&amp;author=T.%20Higashi&amp;author=T.%20Anno&amp;author=K.%20Fujisawa&amp;volume=10&amp;publication_year=2019&amp;pages=2584-2590&amp;pmid=30912637&amp;doi=10.1021/acschemneuro.9b00059&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B29-molecules-25-02213">
<span class="label">29.</span><cite>Bulawa C.E., Connelly S., DeVit M., Wang L., Weigel C., Fleming J.A., Packman J., Powers E.T., Wiseman R.L., Foss T.R., et al.  Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade. Proc. Natl. Acad. Sci. USA. 2012;109:9629–9634. doi: 10.1073/pnas.1121005109.</cite> [<a href="https://doi.org/10.1073/pnas.1121005109" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3386102/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22645360/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proc.%20Natl.%20Acad.%20Sci.%20USA&amp;title=Tafamidis,%20a%20potent%20and%20selective%20transthyretin%20kinetic%20stabilizer%20that%20inhibits%20the%20amyloid%20cascade&amp;author=C.E.%20Bulawa&amp;author=S.%20Connelly&amp;author=M.%20DeVit&amp;author=L.%20Wang&amp;author=C.%20Weigel&amp;volume=109&amp;publication_year=2012&amp;pages=9629-9634&amp;pmid=22645360&amp;doi=10.1073/pnas.1121005109&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B30-molecules-25-02213">
<span class="label">30.</span><cite>Zhao Y., Xin Y., Song Z., He Z., Hu W. Tafamidis, a noninvasive therapy for delaying transthyretin familial amyloid polyneuropathy: Systematic review and meta-analysis. J. Clin. Neurol. 2019;15:108–115. doi: 10.3988/jcn.2019.15.1.108.</cite> [<a href="https://doi.org/10.3988/jcn.2019.15.1.108" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6325356/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30618225/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Clin.%20Neurol.&amp;title=Tafamidis,%20a%20noninvasive%20therapy%20for%20delaying%20transthyretin%20familial%20amyloid%20polyneuropathy:%20Systematic%20review%20and%20meta-analysis&amp;author=Y.%20Zhao&amp;author=Y.%20Xin&amp;author=Z.%20Song&amp;author=Z.%20He&amp;author=W.%20Hu&amp;volume=15&amp;publication_year=2019&amp;pages=108-115&amp;pmid=30618225&amp;doi=10.3988/jcn.2019.15.1.108&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B31-molecules-25-02213">
<span class="label">31.</span><cite>Falk R.H. Tafamidis for transthyretin amyloid cardiomyopathy: The solution or just the beginning of the end? Eur. Heart J. 2019;40:1009–1012. doi: 10.1093/eurheartj/ehy697.</cite> [<a href="https://doi.org/10.1093/eurheartj/ehy697" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30668704/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20Heart%20J.&amp;title=Tafamidis%20for%20transthyretin%20amyloid%20cardiomyopathy:%20The%20solution%20or%20just%20the%20beginning%20of%20the%20end?&amp;author=R.H.%20Falk&amp;volume=40&amp;publication_year=2019&amp;pages=1009-1012&amp;pmid=30668704&amp;doi=10.1093/eurheartj/ehy697&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B32-molecules-25-02213">
<span class="label">32.</span><cite>Sant’Anna R., Gallego P., Robinson L.Z., Pereira-Henriques A., Ferreira N., Pinheiro F., Esperante S., Pallares I., Huertas O., Rosário Almeida M., et al.  Repositioning tolcapone as a potent inhibitor of transthyretin amyloidogenesis and associated cellular toxicity. Nature Commun. 2016;7:10787. doi: 10.1038/ncomms10787.</cite> [<a href="https://doi.org/10.1038/ncomms10787" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4766415/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26902880/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Commun.&amp;title=Repositioning%20tolcapone%20as%20a%20potent%20inhibitor%20of%20transthyretin%20amyloidogenesis%20and%20associated%20cellular%20toxicity&amp;author=R.%20Sant%E2%80%99Anna&amp;author=P.%20Gallego&amp;author=L.Z.%20Robinson&amp;author=A.%20Pereira-Henriques&amp;author=N.%20Ferreira&amp;volume=7&amp;publication_year=2016&amp;pages=10787&amp;pmid=26902880&amp;doi=10.1038/ncomms10787&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B33-molecules-25-02213">
<span class="label">33.</span><cite>Rezania K., Saadat L.  Neurological manifestations of transthyretin-related amyloidosis. In: Kurouski D., editor. Amyloid Diseases. IntechOpen; London, UK: 2019. </cite> [<a href="https://doi.org/10.5772/intechopen.84470" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?title=Amyloid%20Diseases&amp;author=K.%20Rezania&amp;author=L.%20Saadat&amp;publication_year=2019&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B34-molecules-25-02213">
<span class="label">34.</span><cite>Klabunde T., Petrassi H.M., Oza V.B., Raman P., Kelly J.W., Sacchettini J.C. Rational design of potent human transthyretin amyloid disease inhibitors. Nat. Struct. Biol. 2000;7:312–321. doi: 10.1038/74082.</cite> [<a href="https://doi.org/10.1038/74082" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10742177/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Struct.%20Biol.&amp;title=Rational%20design%20of%20potent%20human%20transthyretin%20amyloid%20disease%20inhibitors&amp;author=T.%20Klabunde&amp;author=H.M.%20Petrassi&amp;author=V.B.%20Oza&amp;author=P.%20Raman&amp;author=J.W.%20Kelly&amp;volume=7&amp;publication_year=2000&amp;pages=312-321&amp;pmid=10742177&amp;doi=10.1038/74082&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B35-molecules-25-02213">
<span class="label">35.</span><cite>Palaninathan S.K., Mohamedmohaideed N.N., Orlandini E., Ortore G., Nencetti S., Lapucci A., Rossello A., Freundlich J.S., Sacchettini J.C. Novel transthyretin amyloid fibril formation inhibitors: Synthesis, biological evaluation, and X-ray structural analysis. PLoS ONE. 2009;4:e6290.  doi: 10.1371/journal.pone.0006290.</cite> [<a href="https://doi.org/10.1371/journal.pone.0006290" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2709434/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19621084/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20ONE&amp;title=Novel%20transthyretin%20amyloid%20fibril%20formation%20inhibitors:%20Synthesis,%20biological%20evaluation,%20and%20X-ray%20structural%20analysis&amp;author=S.K.%20Palaninathan&amp;author=N.N.%20Mohamedmohaideed&amp;author=E.%20Orlandini&amp;author=G.%20Ortore&amp;author=S.%20Nencetti&amp;volume=4&amp;publication_year=2009&amp;pages=e6290&amp;pmid=19621084&amp;doi=10.1371/journal.pone.0006290&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B36-molecules-25-02213">
<span class="label">36.</span><cite>Choi S., Reixach N., Connelly S., Johnson S.M., Wilson I.A., Kelly J.W. A substructure combination strategy to create potent and selective transthyretin kinetic stabilizers that prevent amyloidogenesis and cytotoxicity. J. Am. Chem. Soc. 2010;132:1359–1370. doi: 10.1021/ja908562q.</cite> [<a href="https://doi.org/10.1021/ja908562q" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2818972/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20043671/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Am.%20Chem.%20Soc.&amp;title=A%20substructure%20combination%20strategy%20to%20create%20potent%20and%20selective%20transthyretin%20kinetic%20stabilizers%20that%20prevent%20amyloidogenesis%20and%20cytotoxicity&amp;author=S.%20Choi&amp;author=N.%20Reixach&amp;author=S.%20Connelly&amp;author=S.M.%20Johnson&amp;author=I.A.%20Wilson&amp;volume=132&amp;publication_year=2010&amp;pages=1359-1370&amp;pmid=20043671&amp;doi=10.1021/ja908562q&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B37-molecules-25-02213">
<span class="label">37.</span><cite>Ciccone L., Nencetti S., Rossello A., Stura E.A., Orlandini E. Synthesis and structural analysis of halogen substituted fibril formation inhibitors of human transthyretin (TTR) J. Enzyme Inhib. Med. Chem. 2016;31:40–51. doi: 10.3109/14756366.2016.1167048.</cite> [<a href="https://doi.org/10.3109/14756366.2016.1167048" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27067161/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Enzyme%20Inhib.%20Med.%20Chem.&amp;title=Synthesis%20and%20structural%20analysis%20of%20halogen%20substituted%20fibril%20formation%20inhibitors%20of%20human%20transthyretin%20(TTR)&amp;author=L.%20Ciccone&amp;author=S.%20Nencetti&amp;author=A.%20Rossello&amp;author=E.A.%20Stura&amp;author=E.%20Orlandini&amp;volume=31&amp;publication_year=2016&amp;pages=40-51&amp;pmid=27067161&amp;doi=10.3109/14756366.2016.1167048&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B38-molecules-25-02213">
<span class="label">38.</span><cite>Ortore G., Martinelli A. Identification of transthyretin fibril formation inhibitors using structure-based virtual screening. ChemMedChem. 2017;12:1327–1334. doi: 10.1002/cmdc.201700051.</cite> [<a href="https://doi.org/10.1002/cmdc.201700051" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28422428/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ChemMedChem&amp;title=Identification%20of%20transthyretin%20fibril%20formation%20inhibitors%20using%20structure-based%20virtual%20screening&amp;author=G.%20Ortore&amp;author=A.%20Martinelli&amp;volume=12&amp;publication_year=2017&amp;pages=1327-1334&amp;pmid=28422428&amp;doi=10.1002/cmdc.201700051&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B39-molecules-25-02213">
<span class="label">39.</span><cite>Loconte V., Menozzi I., Ferrari A., Folli C., Imbimbo B.P., Zanotti G., Berni R. Structure-activity relationships of flurbiprofen analogues as stabilizers of the amyloidogenic protein transthyretin. J. Struct. Biol. 2019;208:165–173. doi: 10.1016/j.jsb.2019.08.011.</cite> [<a href="https://doi.org/10.1016/j.jsb.2019.08.011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31473362/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Struct.%20Biol.&amp;title=Structure-activity%20relationships%20of%20flurbiprofen%20analogues%20as%20stabilizers%20of%20the%20amyloidogenic%20protein%20transthyretin&amp;author=V.%20Loconte&amp;author=I.%20Menozzi&amp;author=A.%20Ferrari&amp;author=C.%20Folli&amp;author=B.P.%20Imbimbo&amp;volume=208&amp;publication_year=2019&amp;pages=165-173&amp;pmid=31473362&amp;doi=10.1016/j.jsb.2019.08.011&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B40-molecules-25-02213">
<span class="label">40.</span><cite>Gales L., Almeida M.R., Arsequell G., Valencia G., Saraiva M.J., Damas A.M. Iodination of salicylic acid improves its binding to transthyretin. Biochim. Biophys. Acta. 2008;1784:512–517. doi: 10.1016/j.bbapap.2007.11.014.</cite> [<a href="https://doi.org/10.1016/j.bbapap.2007.11.014" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18155178/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochim.%20Biophys.%20Acta&amp;title=Iodination%20of%20salicylic%20acid%20improves%20its%20binding%20to%20transthyretin&amp;author=L.%20Gales&amp;author=M.R.%20Almeida&amp;author=G.%20Arsequell&amp;author=G.%20Valencia&amp;author=M.J.%20Saraiva&amp;volume=1784&amp;publication_year=2008&amp;pages=512-517&amp;pmid=18155178&amp;doi=10.1016/j.bbapap.2007.11.014&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B41-molecules-25-02213">
<span class="label">41.</span><cite>Mairal T., Nieto J., Pinto M., Almeida M.R., Gales L., Ballesteros A., Barluenga J., Pérez J.J., Vázquez J.T., Centeno N.B., et al.  Iodine atoms: A new molecular feature for the design of potent transthyretin fibrillogenesis inhibitors. PLoS ONE. 2009;4:e4124.  doi: 10.1371/journal.pone.0004124.</cite> [<a href="https://doi.org/10.1371/journal.pone.0004124" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2607018/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19125186/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20ONE&amp;title=Iodine%20atoms:%20A%20new%20molecular%20feature%20for%20the%20design%20of%20potent%20transthyretin%20fibrillogenesis%20inhibitors&amp;author=T.%20Mairal&amp;author=J.%20Nieto&amp;author=M.%20Pinto&amp;author=M.R.%20Almeida&amp;author=L.%20Gales&amp;volume=4&amp;publication_year=2009&amp;pages=e4124&amp;pmid=19125186&amp;doi=10.1371/journal.pone.0004124&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B42-molecules-25-02213">
<span class="label">42.</span><cite>Cotrina E.Y., Pinto M., Bosch L., Vilaà M., Blasi D., Quintana J., Centeno N.B., Arsequell G., Planas A., Valencia G. Modulation of the fibrillogenesis inhibition properties of two transthyretin ligands by halogenation. J. Med. Chem. 2013;56:9110–9121. doi: 10.1021/jm401061w.</cite> [<a href="https://doi.org/10.1021/jm401061w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24147937/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Med.%20Chem.&amp;title=Modulation%20of%20the%20fibrillogenesis%20inhibition%20properties%20of%20two%20transthyretin%20ligands%20by%20halogenation&amp;author=E.Y.%20Cotrina&amp;author=M.%20Pinto&amp;author=L.%20Bosch&amp;author=M.%20Vila%C3%A0&amp;author=D.%20Blasi&amp;volume=56&amp;publication_year=2013&amp;pages=9110-9121&amp;pmid=24147937&amp;doi=10.1021/jm401061w&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B43-molecules-25-02213">
<span class="label">43.</span><cite>Ribeiro C.A., Oliveira S.M., Guido L.F., Magalhães A., Valencia G., Arsequell G., Saraiva M.J., Cardoso I. Transthyretin stabilization by iododiflunisal promotes amyloid-β peptide clearance, decreases its deposition, and ameliorates cognitive deficits in an Alzheimer’s disease mouse model. J. Alzheimers Dis. 2014;39:357–370. doi: 10.3233/JAD-131355.</cite> [<a href="https://doi.org/10.3233/JAD-131355" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24169237/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Alzheimers%20Dis.&amp;title=Transthyretin%20stabilization%20by%20iododiflunisal%20promotes%20amyloid-%CE%B2%20peptide%20clearance,%20decreases%20its%20deposition,%20and%20ameliorates%20cognitive%20deficits%20in%20an%20Alzheimer%E2%80%99s%20disease%20mouse%20model&amp;author=C.A.%20Ribeiro&amp;author=S.M.%20Oliveira&amp;author=L.F.%20Guido&amp;author=A.%20Magalh%C3%A3es&amp;author=G.%20Valencia&amp;volume=39&amp;publication_year=2014&amp;pages=357-370&amp;pmid=24169237&amp;doi=10.3233/JAD-131355&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B44-molecules-25-02213">
<span class="label">44.</span><cite>González A., Quirante J., Nieto J., Almeida M.R., Saraiva M.J., Planas A., Arsequell G., Valencia G. Isatin derivatives, a novel class of transthyretin fibrillogenesis inhibitors. Bioorg. Med. Chem. Lett. 2009;19:5270–5273. doi: 10.1016/j.bmcl.2009.03.004.</cite> [<a href="https://doi.org/10.1016/j.bmcl.2009.03.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19651509/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioorg.%20Med.%20Chem.%20Lett.&amp;title=Isatin%20derivatives,%20a%20novel%20class%20of%20transthyretin%20fibrillogenesis%20inhibitors&amp;author=A.%20Gonz%C3%A1lez&amp;author=J.%20Quirante&amp;author=J.%20Nieto&amp;author=M.R.%20Almeida&amp;author=M.J.%20Saraiva&amp;volume=19&amp;publication_year=2009&amp;pages=5270-5273&amp;pmid=19651509&amp;doi=10.1016/j.bmcl.2009.03.004&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B45-molecules-25-02213">
<span class="label">45.</span><cite>Wilcken R., Zimmermann M.O., Lange A., Joerger A.C., Boeckler F.M. Principles and applications of halogen bonding in medicinal chemistry and chemical biology. J. Med. Chem. 2013;56:1363–1388. doi: 10.1021/jm3012068.</cite> [<a href="https://doi.org/10.1021/jm3012068" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23145854/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Med.%20Chem.&amp;title=Principles%20and%20applications%20of%20halogen%20bonding%20in%20medicinal%20chemistry%20and%20chemical%20biology&amp;author=R.%20Wilcken&amp;author=M.O.%20Zimmermann&amp;author=A.%20Lange&amp;author=A.C.%20Joerger&amp;author=F.M.%20Boeckler&amp;volume=56&amp;publication_year=2013&amp;pages=1363-1388&amp;pmid=23145854&amp;doi=10.1021/jm3012068&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B46-molecules-25-02213">
<span class="label">46.</span><cite>Cody V., Murray-Rust P. Iodine···X(O, N, S) intermolecular contacts: Models of thyroid hormone-protein binding interactions using information from the Cambridge Crystallographic Data files. J. Mol. Struct. 1984;112:189–199. doi: 10.1016/0022-2860(84)85061-9.</cite> [<a href="https://doi.org/10.1016/0022-2860(84)85061-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Mol.%20Struct.&amp;title=Iodine%C2%B7%C2%B7%C2%B7X(O,%20N,%20S)%20intermolecular%20contacts:%20Models%20of%20thyroid%20hormone-protein%20binding%20interactions%20using%20information%20from%20the%20Cambridge%20Crystallographic%20Data%20files&amp;author=V.%20Cody&amp;author=P.%20Murray-Rust&amp;volume=112&amp;publication_year=1984&amp;pages=189-199&amp;doi=10.1016/0022-2860(84)85061-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B47-molecules-25-02213">
<span class="label">47.</span><cite>Mamane V., Aubert E., Peluso P., Cossu S. Lithiation of prochiral 2,2′-dichloro-5,5′-dibromo-4,4′-bipyridine as a tool for the synthesis of chiral polyhalogenated 4,4′-bipyridines. J. Org. Chem. 2013;78:7683–7689. doi: 10.1021/jo401255q.</cite> [<a href="https://doi.org/10.1021/jo401255q" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23837459/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Org.%20Chem.&amp;title=Lithiation%20of%20prochiral%202,2%E2%80%B2-dichloro-5,5%E2%80%B2-dibromo-4,4%E2%80%B2-bipyridine%20as%20a%20tool%20for%20the%20synthesis%20of%20chiral%20polyhalogenated%204,4%E2%80%B2-bipyridines&amp;author=V.%20Mamane&amp;author=E.%20Aubert&amp;author=P.%20Peluso&amp;author=S.%20Cossu&amp;volume=78&amp;publication_year=2013&amp;pages=7683-7689&amp;pmid=23837459&amp;doi=10.1021/jo401255q&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B48-molecules-25-02213">
<span class="label">48.</span><cite>Mamane V., Peluso P., Aubert E., Cossu S., Pale P. Chiral hexalogenated 4,4′-bipyridines. J. Org. Chem. 2016;81:4576–4587. doi: 10.1021/acs.joc.6b00413.</cite> [<a href="https://doi.org/10.1021/acs.joc.6b00413" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27149320/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Org.%20Chem.&amp;title=Chiral%20hexalogenated%204,4%E2%80%B2-bipyridines&amp;author=V.%20Mamane&amp;author=P.%20Peluso&amp;author=E.%20Aubert&amp;author=S.%20Cossu&amp;author=P.%20Pale&amp;volume=81&amp;publication_year=2016&amp;pages=4576-4587&amp;pmid=27149320&amp;doi=10.1021/acs.joc.6b00413&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B49-molecules-25-02213">
<span class="label">49.</span><cite>Abboud M., Mamane V., Aubert E., Lecomte C., Fort Y. Synthesis of polyhalogenated 4,4′-bipyridines via a simple dimerization procedure. J. Org. Chem. 2010;75:3224–3231. doi: 10.1021/jo100152e.</cite> [<a href="https://doi.org/10.1021/jo100152e" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20426403/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Org.%20Chem.&amp;title=Synthesis%20of%20polyhalogenated%204,4%E2%80%B2-bipyridines%20via%20a%20simple%20dimerization%20procedure&amp;author=M.%20Abboud&amp;author=V.%20Mamane&amp;author=E.%20Aubert&amp;author=C.%20Lecomte&amp;author=Y.%20Fort&amp;volume=75&amp;publication_year=2010&amp;pages=3224-3231&amp;pmid=20426403&amp;doi=10.1021/jo100152e&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B50-molecules-25-02213">
<span class="label">50.</span><cite>Mamane V., Aubert E., Peluso P., Cossu S. Synthesis, resolution, and absolute configuration of chiral 4,4′-bipyridines. J. Org. Chem. 2012;77:2579–2583. doi: 10.1021/jo300286z.</cite> [<a href="https://doi.org/10.1021/jo300286z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22372669/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Org.%20Chem.&amp;title=Synthesis,%20resolution,%20and%20absolute%20configuration%20of%20chiral%204,4%E2%80%B2-bipyridines&amp;author=V.%20Mamane&amp;author=E.%20Aubert&amp;author=P.%20Peluso&amp;author=S.%20Cossu&amp;volume=77&amp;publication_year=2012&amp;pages=2579-2583&amp;pmid=22372669&amp;doi=10.1021/jo300286z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B51-molecules-25-02213">
<span class="label">51.</span><cite>Peluso P., Mamane V., Aubert E., Dessì A., Dallocchio R., Dore A., Pale P., Cossu S. Insights into halogen bond-driven enantioseparations. J. Chromatogr. A. 2016;146:228–238. doi: 10.1016/j.chroma.2016.06.007.</cite> [<a href="https://doi.org/10.1016/j.chroma.2016.06.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27328882/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Chromatogr.%20A&amp;title=Insights%20into%20halogen%20bond-driven%20enantioseparations&amp;author=P.%20Peluso&amp;author=V.%20Mamane&amp;author=E.%20Aubert&amp;author=A.%20Dess%C3%AC&amp;author=R.%20Dallocchio&amp;volume=146&amp;publication_year=2016&amp;pages=228-238&amp;pmid=27328882&amp;doi=10.1016/j.chroma.2016.06.007&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B52-molecules-25-02213">
<span class="label">52.</span><cite>Dallocchio R., Dessì A., Solinas M., Arras A., Cossu S., Aubert E., Mamane V., Peluso P. Halogen bond in high-performance liquid chromatography enantioseparations: Description, features and modelling. J. Chromatogr. A. 2018;1563:71–81. doi: 10.1016/j.chroma.2018.05.061.</cite> [<a href="https://doi.org/10.1016/j.chroma.2018.05.061" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29871805/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Chromatogr.%20A&amp;title=Halogen%20bond%20in%20high-performance%20liquid%20chromatography%20enantioseparations:%20Description,%20features%20and%20modelling&amp;author=R.%20Dallocchio&amp;author=A.%20Dess%C3%AC&amp;author=M.%20Solinas&amp;author=A.%20Arras&amp;author=S.%20Cossu&amp;volume=1563&amp;publication_year=2018&amp;pages=71-81&amp;pmid=29871805&amp;doi=10.1016/j.chroma.2018.05.061&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B53-molecules-25-02213">
<span class="label">53.</span><cite>Connelly S., Choi S., Johnson S.M., Kelly J.W., Wilson I.A. Structure-based design of kinetic stabilizers that ameliorate the transthyretin amyloidosis. Curr. Opin. Struct. Biol. 2010;20:54–62. doi: 10.1016/j.sbi.2009.12.009.</cite> [<a href="https://doi.org/10.1016/j.sbi.2009.12.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2830738/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20133122/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr.%20Opin.%20Struct.%20Biol.&amp;title=Structure-based%20design%20of%20kinetic%20stabilizers%20that%20ameliorate%20the%20transthyretin%20amyloidosis&amp;author=S.%20Connelly&amp;author=S.%20Choi&amp;author=S.M.%20Johnson&amp;author=J.W.%20Kelly&amp;author=I.A.%20Wilson&amp;volume=20&amp;publication_year=2010&amp;pages=54-62&amp;pmid=20133122&amp;doi=10.1016/j.sbi.2009.12.009&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B54-molecules-25-02213">
<span class="label">54.</span><cite>Politzer P., Murray J.S., Clark T. Halogen bonding and other σ-hole interactions: A perspective. Phys. Chem. Chem. Phys. 2013;15:11178–11189. doi: 10.1039/c3cp00054k.</cite> [<a href="https://doi.org/10.1039/c3cp00054k" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23450152/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Phys.%20Chem.%20Chem.%20Phys.&amp;title=Halogen%20bonding%20and%20other%20%CF%83-hole%20interactions:%20A%20perspective&amp;author=P.%20Politzer&amp;author=J.S.%20Murray&amp;author=T.%20Clark&amp;volume=15&amp;publication_year=2013&amp;pages=11178-11189&amp;pmid=23450152&amp;doi=10.1039/c3cp00054k&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B55-molecules-25-02213">
<span class="label">55.</span><cite>Riley K.E., Tran K.-A., Lane P., Murray J.S., Politzer P. Comparative analysis of electrostatic potential maxima and minima on molecular surfaces, as determined by three methods and a variety of basis sets. J. Comput. Sci. 2016;17:273–284. doi: 10.1016/j.jocs.2016.03.010.</cite> [<a href="https://doi.org/10.1016/j.jocs.2016.03.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Comput.%20Sci.&amp;title=Comparative%20analysis%20of%20electrostatic%20potential%20maxima%20and%20minima%20on%20molecular%20surfaces,%20as%20determined%20by%20three%20methods%20and%20a%20variety%20of%20basis%20sets&amp;author=K.E.%20Riley&amp;author=K.-A.%20Tran&amp;author=P.%20Lane&amp;author=J.S.%20Murray&amp;author=P.%20Politzer&amp;volume=17&amp;publication_year=2016&amp;pages=273-284&amp;doi=10.1016/j.jocs.2016.03.010&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B56-molecules-25-02213">
<span class="label">56.</span><cite>Lange A., Heidrich J., Zimmermann M.O., Exner T.E., Boeckler F.M. Scaffold effect on halogen bonding strength. J. Chem. Inf. Model. 2019;59:885–894. doi: 10.1021/acs.jcim.8b00621.</cite> [<a href="https://doi.org/10.1021/acs.jcim.8b00621" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30629432/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Chem.%20Inf.%20Model.&amp;title=Scaffold%20effect%20on%20halogen%20bonding%20strength&amp;author=A.%20Lange&amp;author=J.%20Heidrich&amp;author=M.O.%20Zimmermann&amp;author=T.E.%20Exner&amp;author=F.M.%20Boeckler&amp;volume=59&amp;publication_year=2019&amp;pages=885-894&amp;pmid=30629432&amp;doi=10.1021/acs.jcim.8b00621&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B57-molecules-25-02213">
<span class="label">57.</span><cite>Wojtczak A., Luft J.R., Cody V. Structural aspects of inotropic bipyridine binding. J. Biol. Chem. 1993;268:6202–6206. doi: 10.2210/pdb1tlm/pdb.</cite> [<a href="https://doi.org/10.2210/pdb1tlm/pdb" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8454595/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Biol.%20Chem.&amp;title=Structural%20aspects%20of%20inotropic%20bipyridine%20binding&amp;author=A.%20Wojtczak&amp;author=J.R.%20Luft&amp;author=V.%20Cody&amp;volume=268&amp;publication_year=1993&amp;pages=6202-6206&amp;pmid=8454595&amp;doi=10.2210/pdb1tlm/pdb&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B58-molecules-25-02213">
<span class="label">58.</span><cite>Pennington L.D., Moustakas D.T. The necessary nitrogen atom: A versatile high-impact design element for multiparameter optimization. J. Med. Chem. 2017;60:3552–3579. doi: 10.1021/acs.jmedchem.6b01807.</cite> [<a href="https://doi.org/10.1021/acs.jmedchem.6b01807" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28177632/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Med.%20Chem.&amp;title=The%20necessary%20nitrogen%20atom:%20A%20versatile%20high-impact%20design%20element%20for%20multiparameter%20optimization&amp;author=L.D.%20Pennington&amp;author=D.T.%20Moustakas&amp;volume=60&amp;publication_year=2017&amp;pages=3552-3579&amp;pmid=28177632&amp;doi=10.1021/acs.jmedchem.6b01807&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B59-molecules-25-02213">
<span class="label">59.</span><cite>Peluso P., Mamane V., Dallocchio R., Dessì A., Villano R., Sanna D., Aubert E., Pale P., Cossu S. Polysaccharide-based chiral stationary phases as halogen bond acceptors: A novel strategy for detection of stereoselective σ-hole bonds in solution. J. Sep. Sci. 2018;41:1247–1256. doi: 10.1002/jssc.201701206.</cite> [<a href="https://doi.org/10.1002/jssc.201701206" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29239526/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Sep.%20Sci.&amp;title=Polysaccharide-based%20chiral%20stationary%20phases%20as%20halogen%20bond%20acceptors:%20A%20novel%20strategy%20for%20detection%20of%20stereoselective%20%CF%83-hole%20bonds%20in%20solution&amp;author=P.%20Peluso&amp;author=V.%20Mamane&amp;author=R.%20Dallocchio&amp;author=A.%20Dess%C3%AC&amp;author=R.%20Villano&amp;volume=41&amp;publication_year=2018&amp;pages=1247-1256&amp;pmid=29239526&amp;doi=10.1002/jssc.201701206&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B60-molecules-25-02213">
<span class="label">60.</span><cite>Wang Z., Sun H., Yao X., Li D., Xu L., Li Y., Tian S., Hou T. Comprehensive evaluation of ten docking programs on a diverse set of protein–ligand complexes: The prediction accuracy of sampling power and scoring power. Phys. Chem. Chem. Phys. 2016;18:12964–12975. doi: 10.1039/C6CP01555G.</cite> [<a href="https://doi.org/10.1039/C6CP01555G" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27108770/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Phys.%20Chem.%20Chem.%20Phys.&amp;title=Comprehensive%20evaluation%20of%20ten%20docking%20programs%20on%20a%20diverse%20set%20of%20protein%E2%80%93ligand%20complexes:%20The%20prediction%20accuracy%20of%20sampling%20power%20and%20scoring%20power&amp;author=Z.%20Wang&amp;author=H.%20Sun&amp;author=X.%20Yao&amp;author=D.%20Li&amp;author=L.%20Xu&amp;volume=18&amp;publication_year=2016&amp;pages=12964-12975&amp;pmid=27108770&amp;doi=10.1039/C6CP01555G&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B61-molecules-25-02213">
<span class="label">61.</span><cite>Irwin J.J., Shoichet B.K. Docking screens for novel ligands conferring new biology. J. Med. Chem. 2016;59:4103–4120. doi: 10.1021/acs.jmedchem.5b02008.</cite> [<a href="https://doi.org/10.1021/acs.jmedchem.5b02008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4865415/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26913380/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Med.%20Chem.&amp;title=Docking%20screens%20for%20novel%20ligands%20conferring%20new%20biology&amp;author=J.J.%20Irwin&amp;author=B.K.%20Shoichet&amp;volume=59&amp;publication_year=2016&amp;pages=4103-4120&amp;pmid=26913380&amp;doi=10.1021/acs.jmedchem.5b02008&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B62-molecules-25-02213">
<span class="label">62.</span><cite>Ferreira L.G., dos Santos R.N., Oliva G., Andricopulo A.D. Molecular docking and structure-based drug design strategies. Molecules. 2015;20:13384–13421. doi: 10.3390/molecules200713384.</cite> [<a href="https://doi.org/10.3390/molecules200713384" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6332083/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26205061/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecules&amp;title=Molecular%20docking%20and%20structure-based%20drug%20design%20strategies&amp;author=L.G.%20Ferreira&amp;author=R.N.%20dos%20Santos&amp;author=G.%20Oliva&amp;author=A.D.%20Andricopulo&amp;volume=20&amp;publication_year=2015&amp;pages=13384-13421&amp;pmid=26205061&amp;doi=10.3390/molecules200713384&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B63-molecules-25-02213">
<span class="label">63.</span><cite>Adcock S.A., McCammon J.A. Molecular dynamics: Survey of methods for simulating the activity of proteins. Chem. Rev. 2006;106:1589–1615. doi: 10.1021/cr040426m.</cite> [<a href="https://doi.org/10.1021/cr040426m" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2547409/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16683746/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Chem.%20Rev.&amp;title=Molecular%20dynamics:%20Survey%20of%20methods%20for%20simulating%20the%20activity%20of%20proteins&amp;author=S.A.%20Adcock&amp;author=J.A.%20McCammon&amp;volume=106&amp;publication_year=2006&amp;pages=1589-1615&amp;pmid=16683746&amp;doi=10.1021/cr040426m&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B64-molecules-25-02213">
<span class="label">64.</span><cite>De Lima W.E.A., Pereira A.F., de Castro A.A., de Cunha E.F.F., Ramalho T.C. Flexibility in the molecular design of acetylcholinesterase reactivators: Probing representative conformations by chemometric techniques and docking/QM calculations. Lett. Drug Des. Discov. 2016;13:360–371. doi: 10.2174/1570180812666150918191550.</cite> [<a href="https://doi.org/10.2174/1570180812666150918191550" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lett.%20Drug%20Des.%20Discov.&amp;title=Flexibility%20in%20the%20molecular%20design%20of%20acetylcholinesterase%20reactivators:%20Probing%20representative%20conformations%20by%20chemometric%20techniques%20and%20docking/QM%20calculations&amp;author=W.E.A.%20De%20Lima&amp;author=A.F.%20Pereira&amp;author=A.A.%20de%20Castro&amp;author=E.F.F.%20de%20Cunha&amp;author=T.C.%20Ramalho&amp;volume=13&amp;publication_year=2016&amp;pages=360-371&amp;doi=10.2174/1570180812666150918191550&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B65-molecules-25-02213">
<span class="label">65.</span><cite>Fine J., Konc J., Samudrala R., Chopra G. CANDOCK: Chemical atomic network-based hierarchical flexible docking algorithm using generalized statistical potentials. J. Chem. Inf. Model. 2020;60:1509–1527. doi: 10.1021/acs.jcim.9b00686.</cite> [<a href="https://doi.org/10.1021/acs.jcim.9b00686" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12034428/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32069042/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Chem.%20Inf.%20Model.&amp;title=CANDOCK:%20Chemical%20atomic%20network-based%20hierarchical%20flexible%20docking%20algorithm%20using%20generalized%20statistical%20potentials&amp;author=J.%20Fine&amp;author=J.%20Konc&amp;author=R.%20Samudrala&amp;author=G.%20Chopra&amp;volume=60&amp;publication_year=2020&amp;pages=1509-1527&amp;pmid=32069042&amp;doi=10.1021/acs.jcim.9b00686&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B66-molecules-25-02213">
<span class="label">66.</span><cite>Zhu J., Wu Y., Xu L., Jin J. Theoretical studies on the selectivity mechanisms of glycogen synthase kinase 3β (GSK3β) with pyrazine ATP-competitive inhibitors by 3DQSAR, molecular docking, molecular dynamics simulation and free energy calculations. Curr. Comput.-Aided Drug Des. 2020;16:17–30. doi: 10.2174/1573409915666190708102459.</cite> [<a href="https://doi.org/10.2174/1573409915666190708102459" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6967214/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31284868/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr.%20Comput.-Aided%20Drug%20Des.&amp;title=Theoretical%20studies%20on%20the%20selectivity%20mechanisms%20of%20glycogen%20synthase%20kinase%203%CE%B2%20(GSK3%CE%B2)%20with%20pyrazine%20ATP-competitive%20inhibitors%20by%203DQSAR,%20molecular%20docking,%20molecular%20dynamics%20simulation%20and%20free%20energy%20calculations&amp;author=J.%20Zhu&amp;author=Y.%20Wu&amp;author=L.%20Xu&amp;author=J.%20Jin&amp;volume=16&amp;publication_year=2020&amp;pages=17-30&amp;pmid=31284868&amp;doi=10.2174/1573409915666190708102459&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B67-molecules-25-02213">
<span class="label">67.</span><cite>Shen C., Wang Z., Yao X., Li Y., Lei T., Wang E., Xu L., Zhu F., Li D., Hou T. Comprehensive assessment of nine docking programs on type II kinase inhibitors: Prediction accuracy of sampling power, scoring power and screening power. Brief. Bioinform. 2020;21:282–297. doi: 10.1093/bib/bby103.</cite> [<a href="https://doi.org/10.1093/bib/bby103" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30379986/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Brief.%20Bioinform.&amp;title=Comprehensive%20assessment%20of%20nine%20docking%20programs%20on%20type%20II%20kinase%20inhibitors:%20Prediction%20accuracy%20of%20sampling%20power,%20scoring%20power%20and%20screening%20power&amp;author=C.%20Shen&amp;author=Z.%20Wang&amp;author=X.%20Yao&amp;author=Y.%20Li&amp;author=T.%20Lei&amp;volume=21&amp;publication_year=2020&amp;pages=282-297&amp;pmid=30379986&amp;doi=10.1093/bib/bby103&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B68-molecules-25-02213">
<span class="label">68.</span><cite>Morris G.M., Goodsell D.S., Halliday R.S., Huey R., Hart W.E., Belew R.K., Olson A.J. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J. Comput. Chem. 1998;19:1639–1662. doi: 10.1002/(SICI)1096-987X(19981115)19:14&amp;#x0003c;1639::AID-JCC10&amp;#x0003e;3.0.CO;2-B.</cite> [<a href="https://doi.org/10.1002/(SICI)1096-987X(19981115)19:14&amp;#x0003c;1639::AID-JCC10&amp;#x0003e;3.0.CO;2-B" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Comput.%20Chem.&amp;title=Automated%20docking%20using%20a%20Lamarckian%20genetic%20algorithm%20and%20an%20empirical%20binding%20free%20energy%20function&amp;author=G.M.%20Morris&amp;author=D.S.%20Goodsell&amp;author=R.S.%20Halliday&amp;author=R.%20Huey&amp;author=W.E.%20Hart&amp;volume=19&amp;publication_year=1998&amp;pages=1639-1662&amp;doi=10.1002/(SICI)1096-987X(19981115)19:14&amp;#x0003c;1639::AID-JCC10&amp;#x0003e;3.0.CO;2-B&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B69-molecules-25-02213">
<span class="label">69.</span><cite>Huey R., Morris G.M., Olson A.J., Goodsell D.S. A semiempirical free energy force field with charge-based desolvation. J. Comput. Chem. 2007;28:1145–1152. doi: 10.1002/jcc.20634.</cite> [<a href="https://doi.org/10.1002/jcc.20634" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17274016/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Comput.%20Chem.&amp;title=A%20semiempirical%20free%20energy%20force%20field%20with%20charge-based%20desolvation&amp;author=R.%20Huey&amp;author=G.M.%20Morris&amp;author=A.J.%20Olson&amp;author=D.S.%20Goodsell&amp;volume=28&amp;publication_year=2007&amp;pages=1145-1152&amp;pmid=17274016&amp;doi=10.1002/jcc.20634&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B70-molecules-25-02213">
<span class="label">70.</span><cite>Pettersen E.F., Goddard T.D., Huang C.C., Couch G.S., Greenblatt D.M., Meng E.C., Ferrin T.E. UCSF Chimera - a visualization system for exploratory research and analysis. J. Comput. Chem. 2004;25:1605–1612. doi: 10.1002/jcc.20084.</cite> [<a href="https://doi.org/10.1002/jcc.20084" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15264254/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Comput.%20Chem.&amp;title=UCSF%20Chimera%20-%20a%20visualization%20system%20for%20exploratory%20research%20and%20analysis&amp;author=E.F.%20Pettersen&amp;author=T.D.%20Goddard&amp;author=C.C.%20Huang&amp;author=G.S.%20Couch&amp;author=D.M.%20Greenblatt&amp;volume=25&amp;publication_year=2004&amp;pages=1605-1612&amp;pmid=15264254&amp;doi=10.1002/jcc.20084&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B71-molecules-25-02213">
<span class="label">71.</span><cite>Ibrahim M.A.A. Molecular mechanical study of halogen bonding in drug discovery. J. Comput. Chem. 2011;32:2564–2574. doi: 10.1002/jcc.21836.</cite> [<a href="https://doi.org/10.1002/jcc.21836" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21598284/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Comput.%20Chem.&amp;title=Molecular%20mechanical%20study%20of%20halogen%20bonding%20in%20drug%20discovery&amp;author=M.A.A.%20Ibrahim&amp;volume=32&amp;publication_year=2011&amp;pages=2564-2574&amp;pmid=21598284&amp;doi=10.1002/jcc.21836&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B72-molecules-25-02213">
<span class="label">72.</span><cite>Ibrahim M.A.A. Molecular mechanical perspective on halogen bonding. J. Mol. Model. 2012;18:4625–4638. doi: 10.1007/s00894-012-1454-8.</cite> [<a href="https://doi.org/10.1007/s00894-012-1454-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22643975/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Mol.%20Model.&amp;title=Molecular%20mechanical%20perspective%20on%20halogen%20bonding&amp;author=M.A.A.%20Ibrahim&amp;volume=18&amp;publication_year=2012&amp;pages=4625-4638&amp;pmid=22643975&amp;doi=10.1007/s00894-012-1454-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B73-molecules-25-02213">
<span class="label">73.</span><cite>Kolář M.H., Hobza P., Bronowska K. Plugging the explicit σ-holes in molecular docking. Chem. Commun. 2013;49:981–983. doi: 10.1039/C2CC37584B.</cite> [<a href="https://doi.org/10.1039/C2CC37584B" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23257988/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Chem.%20Commun.&amp;title=Plugging%20the%20explicit%20%CF%83-holes%20in%20molecular%20docking&amp;author=M.H.%20Kol%C3%A1%C5%99&amp;author=P.%20Hobza&amp;author=K.%20Bronowska&amp;volume=49&amp;publication_year=2013&amp;pages=981-983&amp;pmid=23257988&amp;doi=10.1039/C2CC37584B&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B74-molecules-25-02213">
<span class="label">74.</span><cite>Kolář M.H., Hobza P. On extension of the current biomolecular empirical force field for the description of halogen bonds. J. Chem. Theory Comput. 2012;8:1325–1333. doi: 10.1021/ct2008389.</cite> [<a href="https://doi.org/10.1021/ct2008389" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26596748/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Chem.%20Theory%20Comput.&amp;title=On%20extension%20of%20the%20current%20biomolecular%20empirical%20force%20field%20for%20the%20description%20of%20halogen%20bonds&amp;author=M.H.%20Kol%C3%A1%C5%99&amp;author=P.%20Hobza&amp;volume=8&amp;publication_year=2012&amp;pages=1325-1333&amp;pmid=26596748&amp;doi=10.1021/ct2008389&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B75-molecules-25-02213">
<span class="label">75.</span><cite>Fanfrlík J., Ruiz F.X., Kadlčíková A., Řezáč J., Cousido-Siah A., Mitschler A., Haldar S., Lepšík M., Kolář M.H., Majer P., et al.  The effect of halogen-to-hydrogen bond substitution on human aldose reductase inhibition. ACS Chem. Biol. 2015;10:1637–1642. doi: 10.1021/acschembio.5b00151.</cite> [<a href="https://doi.org/10.1021/acschembio.5b00151" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25919404/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACS%20Chem.%20Biol.&amp;title=The%20effect%20of%20halogen-to-hydrogen%20bond%20substitution%20on%20human%20aldose%20reductase%20inhibition&amp;author=J.%20Fanfrl%C3%ADk&amp;author=F.X.%20Ruiz&amp;author=A.%20Kadl%C4%8D%C3%ADkov%C3%A1&amp;author=J.%20%C5%98ez%C3%A1%C4%8D&amp;author=A.%20Cousido-Siah&amp;volume=10&amp;publication_year=2015&amp;pages=1637-1642&amp;pmid=25919404&amp;doi=10.1021/acschembio.5b00151&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B76-molecules-25-02213">
<span class="label">76.</span><cite>Arsequell G., Planas A. Methods to evaluate the inhibition of TTR fibrillogenesis induced by small ligands. Curr. Med. Chem. 2012;19:2343–2455. doi: 10.2174/092986712800269281.</cite> [<a href="https://doi.org/10.2174/092986712800269281" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22471983/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr.%20Med.%20Chem.&amp;title=Methods%20to%20evaluate%20the%20inhibition%20of%20TTR%20fibrillogenesis%20induced%20by%20small%20ligands&amp;author=G.%20Arsequell&amp;author=A.%20Planas&amp;volume=19&amp;publication_year=2012&amp;pages=2343-2455&amp;pmid=22471983&amp;doi=10.2174/092986712800269281&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B77-molecules-25-02213">
<span class="label">77.</span><cite>Dolado I., Nieto J., Saraiva M.J., Arsequell G., Valencia G., Planas A. Kinetic assay for high-throughput screening of in vitro transthyretin amyloid fibrillogenesis inhibitors. J. Comb. Chem. 2005;7:246–252. doi: 10.1021/cc049849s.</cite> [<a href="https://doi.org/10.1021/cc049849s" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15762752/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Comb.%20Chem.&amp;title=Kinetic%20assay%20for%20high-throughput%20screening%20of%20in%20vitro%20transthyretin%20amyloid%20fibrillogenesis%20inhibitors&amp;author=I.%20Dolado&amp;author=J.%20Nieto&amp;author=M.J.%20Saraiva&amp;author=G.%20Arsequell&amp;author=G.%20Valencia&amp;volume=7&amp;publication_year=2005&amp;pages=246-252&amp;pmid=15762752&amp;doi=10.1021/cc049849s&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B78-molecules-25-02213">
<span class="label">78.</span><cite>Weiss R., Aubert E., Peluso P., Cossu S., Pale P., Mamane V. Chiral chalcogen bond donors based on the 4,4′-bipyridine scaffold. Molecules. 2019;24:4484.  doi: 10.3390/molecules24244484.</cite> [<a href="https://doi.org/10.3390/molecules24244484" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6943643/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31817814/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecules&amp;title=Chiral%20chalcogen%20bond%20donors%20based%20on%20the%204,4%E2%80%B2-bipyridine%20scaffold&amp;author=R.%20Weiss&amp;author=E.%20Aubert&amp;author=P.%20Peluso&amp;author=S.%20Cossu&amp;author=P.%20Pale&amp;volume=24&amp;publication_year=2019&amp;pages=4484&amp;pmid=31817814&amp;doi=10.3390/molecules24244484&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B79-molecules-25-02213">
<span class="label">79.</span><cite>Jiang X., Buxbaum J.N., Kelly J.W. The V122I cardiomyopathy variant of transthyretin increases the velocity of rate-limiting tetramer dissociation, resulting in accelerated amyloidosis. Proc. Natl. Acad. Sci. USA. 2001;98:14943–14948. doi: 10.1073/pnas.261419998.</cite> [<a href="https://doi.org/10.1073/pnas.261419998" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC64963/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11752443/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proc.%20Natl.%20Acad.%20Sci.%20USA&amp;title=The%20V122I%20cardiomyopathy%20variant%20of%20transthyretin%20increases%20the%20velocity%20of%20rate-limiting%20tetramer%20dissociation,%20resulting%20in%20accelerated%20amyloidosis&amp;author=X.%20Jiang&amp;author=J.N.%20Buxbaum&amp;author=J.W.%20Kelly&amp;volume=98&amp;publication_year=2001&amp;pages=14943-14948&amp;pmid=11752443&amp;doi=10.1073/pnas.261419998&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B80-molecules-25-02213">
<span class="label">80.</span><cite>Shao Y., Molnar L.F., Jung Y., Kussmann J., Ochsenfeld C., Brown S.T., Gilbert A.T.B., Slipchenko L.V., Levchenko S.V., O’Neil D.P., et al.  Advances in methods and algorithms in a modern quantum chemistry program package. Phys. Chem. Chem. Phys. 2006;8:3172–3191. doi: 10.1039/B517914A.</cite> [<a href="https://doi.org/10.1039/B517914A" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16902710/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Phys.%20Chem.%20Chem.%20Phys.&amp;title=Advances%20in%20methods%20and%20algorithms%20in%20a%20modern%20quantum%20chemistry%20program%20package&amp;author=Y.%20Shao&amp;author=L.F.%20Molnar&amp;author=Y.%20Jung&amp;author=J.%20Kussmann&amp;author=C.%20Ochsenfeld&amp;volume=8&amp;publication_year=2006&amp;pages=3172-3191&amp;pmid=16902710&amp;doi=10.1039/B517914A&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B81-molecules-25-02213">
<span class="label">81.</span><cite>Frisch M.J., Trucks G.W., Schlegel H.B., Scuseria G.E., Robb M.A., Cheeseman J.R., Scalmani G., Barone V., Mennucci B., Petersson G.A., et al.   Gaussian 09, Revision B. 01. Gaussian, Inc.; Wallingford, CT, USA: 2010. </cite> [<a href="https://scholar.google.com/scholar_lookup?title=Gaussian%2009,%20Revision%20B.%2001&amp;author=M.J.%20Frisch&amp;author=G.W.%20Trucks&amp;author=H.B.%20Schlegel&amp;author=G.E.%20Scuseria&amp;author=M.A.%20Robb&amp;publication_year=2010&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B82-molecules-25-02213">
<span class="label">82.</span><cite>Lu T., Chen F. Multiwfn: A multifunctional wavefunction analyser. J. Comp.Chem. 2012;33:580–592. doi: 10.1002/jcc.22885.</cite> [<a href="https://doi.org/10.1002/jcc.22885" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22162017/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Comp.Chem.&amp;title=Multiwfn:%20A%20multifunctional%20wavefunction%20analyser&amp;author=T.%20Lu&amp;author=F.%20Chen&amp;volume=33&amp;publication_year=2012&amp;pages=580-592&amp;pmid=22162017&amp;doi=10.1002/jcc.22885&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B83-molecules-25-02213">
<span class="label">83.</span><cite>Lu T., Chen F. Quantitative analysis of molecular surface based on improved marching tetrahedra algorithm. J. Mol. Graph. Model. 2012;38:314–323. doi: 10.1016/j.jmgm.2012.07.004.</cite> [<a href="https://doi.org/10.1016/j.jmgm.2012.07.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23085170/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Mol.%20Graph.%20Model.&amp;title=Quantitative%20analysis%20of%20molecular%20surface%20based%20on%20improved%20marching%20tetrahedra%20algorithm&amp;author=T.%20Lu&amp;author=F.%20Chen&amp;volume=38&amp;publication_year=2012&amp;pages=314-323&amp;pmid=23085170&amp;doi=10.1016/j.jmgm.2012.07.004&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B84-molecules-25-02213">
<span class="label">84.</span><cite>Gasteiger J., Marsili M. Iterative partial equalization of orbital electronegativity -a rapid access to atomic charges. Tetrahedron. 1980;36:3219–3228. doi: 10.1016/0040-4020(80)80168-2.</cite> [<a href="https://doi.org/10.1016/0040-4020(80)80168-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Tetrahedron&amp;title=Iterative%20partial%20equalization%20of%20orbital%20electronegativity%20-a%20rapid%20access%20to%20atomic%20charges&amp;author=J.%20Gasteiger&amp;author=M.%20Marsili&amp;volume=36&amp;publication_year=1980&amp;pages=3219-3228&amp;doi=10.1016/0040-4020(80)80168-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B85-molecules-25-02213">
<span class="label">85.</span><cite>Sanner M.F. Python: A programming language for software integration and development. J. Mol. Graph. Model. 1999;17:57–61.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/10660911/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Mol.%20Graph.%20Model.&amp;title=Python:%20A%20programming%20language%20for%20software%20integration%20and%20development&amp;author=M.F.%20Sanner&amp;volume=17&amp;publication_year=1999&amp;pages=57-61&amp;pmid=10660911&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B86-molecules-25-02213">
<span class="label">86.</span><cite>Dennington R., Keith T., Millam J.  GaussView Version 5. Semichem Inc.; Shawnee Mission, KS, USA: 2009. </cite> [<a href="https://scholar.google.com/scholar_lookup?title=GaussView%20Version%205&amp;author=R.%20Dennington&amp;author=T.%20Keith&amp;author=J.%20Millam&amp;publication_year=2009&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/7248964/bin/molecules-25-02213-s001.pdf" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (2.4MB, pdf) </sup>
</div></div></section></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Molecules are provided here courtesy of <strong>Multidisciplinary Digital Publishing Institute  (MDPI)</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.3390/molecules25092213"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/molecules-25-02213.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (3.0 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/7248964/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/7248964/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC7248964%2F%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC7248964/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC7248964/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC7248964/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/32397334/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC7248964/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/32397334/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC7248964/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/7248964/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="d7X09Kpi8ChoAS0C0zGDzOQLKUoo3598eQKHCvNu5YwUUljXeNLjnsilvIEYGFQM">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
